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ABSTRACT
Synthesis of 4’-Ester Resveratrol Analogues, Chromium Trioxide
Oxidation of Terpenes, and Synthesis of
Mimics of (–)-Englerin A
Mark Jeffrey Acerson
Department of Chemistry and Biochemistry, BYU
Doctor of Philosophy
4’-ester analogues of resveratrol were synthesized using reaction conditions developed to
produce mono-ester products in the presence of two other unprotected phenols. Basic conditions
were employed to deprotonate the most acidic 4’ phenol followed by addition of anhydrides or
acid chlorides to give the ester product. The reaction favored 4’-ester formation in polar aprotic
solvents with DMSO being the optimal solvent.
(–)-Englerin A is a guaiane-type sesquiterpene containing two ester side chains. Mimics
of (–)-englerin A were proposed that retained the ester side chains while replacing the non-polar
core with less complicated structures. These proposed mimic cores would maintain the threedimensional positioning of the esters which are responsible for the anti-cancer activity of (–)englerin A. Three mimics were synthesized using the bicyclic terpenes borneol and fenchol.
Installation of the second ester on the terpene core was accomplished throught the development
and optimization of a unique methylene oxidation using chromium trioxide in glacial acetic acid.
These mimics were screened against two kidney cancer cell lines. The compounds were shown
to have IC50 (inhibitory concentration for 50 % of cells) values above 30 μM.

Keywords: resveratrol, englerin A, analogue, mimic, polyphenol, anti-viral, anti-cancer,
methylene oxidation, selective esterification
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1. Synthesis of 4’-Ester Resveratrol Analogues and Evaluation of Anti-cancer Activity
1.1 Introduction
1.1.1

Discovery
Resveratrol (Figure 1) is a phytoalexin that was first

isolated from the roots of the hellebore lily in 1940.1 It is
one of many naturally occurring polyphenolic compounds
typically isolated from plants. Other examples of
polyphenols include genistein, equol, phloretin, isovitexin,

Figure 1. Resveratrol

corilagin, and epigallocatechin gallate. Resveratrol has also been found in grapes, peanuts, and
soybeans in significant quantities.2 The most plentiful source of resveratrol is from the roots of
Polygonium cuspidatum. Most nutritional supplements containing resveratrol are produced
using extracts from these roots. Higher levels of resveratrol production can be achieved by
stressing the plant through injury, exposure to ultraviolet light, or contraction of a fungal
infection.
The ancient Chinese and Japanese used the roots of Polygonium cuspidatum in their
herbal remedies. In Asia, the dried powdered roots were used as a treatment for atherosclerosis,
asthma, hypertension, and cancer. Polygonium cuspidatum was originally from China, but has
spread to Japan and even to North America where it has become known as Japanese Knotweed.
It has become quite a resilient invasive species due to its growth characteristics. Resveratrol can
be isolated from the roots at approximately 5.3 mg per gram of dry powdered root.

1

1.1.2

Biological Activity
Resveratrol has been shown to have a plethora of biological activities. Some of these

include radical scavenging, lipid modification, platelet aggregation inhibition, antiviral,
antioxidant, and extended life cycle in yeast.3,4
It has also been shown through cell assays that resveratrol is a cancer preventive
compound. Possible mechanisms of action for resveratrol include inhibition of cyclooxygenase
enzymes COX–1 and COX–2 and angiogenesis inhibition.5
Resveratrol inhibits cyclooxygenase enzymes COX–1 and COX–2. Inhibition of
cyclooxygenase enzymes for long periods of time has shown a protective effect against
colorectal cancer in a mouse model.6 APCΔ716 (human familial adenomatous polyposis) mice
were used to produce a COX–2 enzyme knockout phenotype. The mice were then allowed to
develop intestinal polyps. The control group of mice developed approximately three times as
many polyps as those mice lacking the COX–2 enzyme. It was further shown that resveratrol’s
ability to reduce polyp formation was due to reduced expression of COX-2 cyclooxygenase
enzyme at the mRNA level.7
Resveratrol was shown to inhibit angiogenesis in a highly-metastatic, drug resistant LLC
(lewis lung carcinoma) mouse model.8 Angiogenesis is key to tumor growth. Without nutrients
a solid tumor begins to undergo necrosis from a lack of oxygen. The mouse study showed that
when treated with resveratrol for 21 days the mice showed no metastatic growth. The resveratrol
inhibited DNA synthesis and induced apoptosis in the target LLC cancer cells. It was also
shown to inhibit angiogenesis in human breast cancer xenografts in vivo.9

2

1.1.3

Total Synthesis of Resveratrol and Analogues
Resveratrol can be isolated from natural sources in large quantities. Dried grape skins

can yield 92 mg/kg but purity of the material is far from desirable.10 Thus a total synthesis
would be profitable if the route could be both high yielding and contaminant free.
Since the discovery of resveratrol, there have been countless total syntheses published.
The first total synthesis of resveratrol was completed by Takaoka1 et. al. This route utilized a
Perkin condensation to couple 3,5-dimethoxyphenylacetate to 4-methoxybenzaldehyde in acetic
anhydride (Figure 2). The efficiency for this route is unknown due to no yields being reported
for this process.

Figure 2. Resveratrol synthesis using Perkin condensation
Other groups have employed Wittig and Horner-Emmons couplings to afford resveratrol
in 7–8 steps.11–17 However, these routes used protecting groups that are difficult to remove due
to sub optimal deprotection conditions. One example is a synthetic route reported by Alonso18
et. al. which employs methyl ether protecting groups which required removal using methyl
magnesium iodide at high temperature (Figure 3). This route also features organolithium
formation which is used to couple the desired aldehyde giving the resulting alcohol. These
coupling reactions proved to be low yielding across all examined substrates.
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Figure 3. Resveratrol synthesis using organolithium coupling
Coupling the two aryl groups in resveratrol together using a metal catalyst was the next
step in improving the synthetic route to resveratrol. Several groups used the Heck reaction to
couple aryl halides to appropriate styrene derivatives while most recently Andrus et. al. reported
a synthetic route to resveratrol that allows for various ester analogues to be synthesized while
giving a high overall yield using a decarbonylative Heck reaction.4,19–21
The route reported by Andrus4 et. al. takes only four steps and uses commercially
available resorcylic acid and 4-acetoxystyrene for its starting materials (Figure 4). The
resorcylic acid is converted to the corresponding acid chloride after phenol protection with acetic
anhydride and then coupled to 4-acetoxystyrene using a decarbonylative Heck reaction with
palladium acetate and an N-heterocyclic carbene (NHC) ligand. The acetate protecting groups
were then easily removed with sodium hydroxide to produce the desired resveratrol product.

4

Figure 4. Resveratrol synthesis using decarbonylative Heck coupling
1.1.4

Mono-esterification of Polyphenols
Esterification of phenols and alcohols are two modifications that are commonly used in

adjusting ADMET properties of drugs.22 This is a common solution for permeability problems.
Esterification with short fatty acid chains can improve permeability of compounds by up to three
orders of magnitude. One example of a drug that utilizes this modification is enalapril. Often
there are multiple alcohols or phenols within a single compound which could complicate the use
of this method. Possible inactivation of a compound could occur if an essential alcohol needed
for binding is esterified.
Resveratrol is one of many polyphenols isolated from natural sources. It has been shown
that the 4’-acetate analogue of resveratrol exhibits the same biological activity as resveratrol in
two melanoma cell lines but has improved absorption, distribution, metabolism, excretion, and
toxicity (ADMET) properties.21 Thus the 4’-ester of resveratrol likely increases absorption and
then is quickly hydrolyzed by an esterase once it reaches cells. Many such modifications of
natural products are made to improve their ADMET properties thus increasing their use as drugs.

5

Being able to selectively modify a chemically diverse molecule gives a chemist the ability to
manipulate a chemical structure and improve upon it.
There are few examples in the literature of selective esterification techniques used with
polyphenol compounds. Two methods that have been reported both utilize lipases to selectively
hydrolyze esters and esterify phenols.
Nicolosi23 et. al. was able to synthesize acetate analogues of resveratrol in 2002 using
antarctina lipase, vinyl acetate, and t–amyl alcohol. This process was able to yield 4’acetylresveratrol as the only product after 90 hours of reaction time. Although the selectivity for
producing the single ester product was good, the yield for the process was only 40%. Attempting
to access other mono-esters of resveratrol was accomplished by carrying out an alcoholysis of
the 3,5,4’-triacetylresveratrol using the same antarctina lipase with n-butanol. After a few
minutes of reacting, 3,5-diacetylresveratrol was observed and upon further exposure for 15
minutes both 3,5-diacetylresveratrol and 3-acetylresveratrol were present. The conversion of the
triacetate to the corresponding mono- and diacetylresveratrol compounds was measured to be
30%. The same reaction carried out with the lipase PcL was more selective yielding 95% of the
3,5-diacetylresveratrol.
In 2010, Torres24 et. al. also attempted to use lipases to produce selectively esterified
resveratrol analogues. They were able to screen several lipases and found six that were able to
sufficiently catalyze the esterification of resveratrol. The lipase QLG from alcaligenes sp. was
shown to selectively esterify the 3-hydroxyl group while lipase B from candida antarctica was
selective for the 4’-hydroxyl group. After optimization of the reaction conditions, Torres et. al.
were able to obtain a 75% yield of 3-acetoxyresveratrol after 12 hours and 80% yield for 4’-
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acetoxyresveratrol after 50 hours. These were by far the best results for producing selective
esterification of polyphenol compounds reported.
1.2 Results and Discussion
1.2.1

Synthesis of Mono-Ester Analogues of Resveratrol
The method used to synthesize 4’-acetyl analogues of resveratrol described in this work

was published by Andrus21 et. al. in 2010. The synthesis uses inexpensive resorcylic acid as the
starting material. Protection of the phenols with benzyl groups and transformation to the acid
chloride allowed for coupling to 4-acetoxystyrene. A decarbonylative Heck reaction using
palladium acetate affords the resveratrol framework. Final deprotection of the benzyl protecting
groups yields 4’-acetoxyresveratrol. Prior to deprotection, hydrolysis of the acetate and
subsequent esterification with the appropriate acetyl group allows access to various analogues of
resveratrol.
Resorcylic acid was treated with methanol and catalytic H2SO4 to give the corresponding
methyl ester (Figure 5). Two equivalents of benzyl bromide in DMF with K2CO3 efficiently
protected the free hydroxyls. The methyl ester was then hydrolyzed with NaOH followed by
treatment with SOCl2 to give the acid chloride. Using catalytic Pd(OAc)2 (1 mol%) and NHC
ligand afforded 1 when coupled with 4-acetoxystyrene. This intermediate, 3,5-dibenzyl-4’acetylresveratrol, can easily be modified to access the desired analogues.
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Figure 5. Synthesis of 3,5-dibenzyl-4’-acetylresveratrol 1
Compound 1 when exposed to KOH in EtOH gave the free phenol 2 (Figure 6). Using pivaloyl
chloride and pyridine gives ester 3. Final deprotection of the benzyl groups is accomplished by
addition of 16 equivalents of BF3·OEt2 and Me2S in DCM produced the final 4’-pivalate ester 4
of resveratrol. The 4’-benzoate ester 6 was also synthesized by this method in good yield. Other
analogues can be accessed using other acid chlorides.

Figure 6. 4’-Ester analogue synthesis
Although the above described method of obtaining 4’-ester analogues of resveratrol is very
efficient, a direct selective esterification of resveratrol was pursued. Investigation of conditions
8

suitable for this transformation began with use of acetyl chloride with pyridine. However, this
standard method led to over acylation of resveratrol giving predominately 3,5,4’triacetoxystilbene. Using basic conditions of NaOH and acetic anhydride in H2O gave mostly
monoacylated products. The ratio of 4’-acetoxyresveratrol (4’-AR) to 3-acetoxyresveratrol (3AR) was analyzed by proton NMR (Figure 7). The proton signal at C4 of the resveratrol
structure is upfield from the other aromatic signals making identification of various mono-esters
convenient. Comparison of previously synthesized 3-, 4’-acetylresveratrol, and resveratrol
proton NMR spectra to reaction mixtures confirmed assignment of the C4 peak for each
compound. The observed ratio of 4’- to 3-acetoxyresveratrol was 1.0:1.2. With preliminary
results in place and a method for easy identification of resulting products, solvent optimization
was pursued first.

Figure 7. 1H NMR identification of mono-ester resveratrol analogues
Initial reactions performed in H2O showed preferential formation of the undesired 3acetoxyresveratrol (Table 1). EtOH gave similar results although K2CO3 was used as the base.
Switching to a polar aprotic solvent was then investigated. Acetone and THF showed selectivity
for 4’-ester formation. This selectivity is attributed to both the polarity and aprotic properties of
the solvent. A polar solvent allows for greater ionization of resveratrol leading to more esterified
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product. Aprotic conditions allow for minimal scrambling of the initial anion formed at the 4’
position. This is key to minimizing polyacylation of resveratrol. If anion scrambling occurs,
then polyacylation rapidly converts mono-acyl resveratrol to di- and tri-acyl resveratrol leaving
much of the starting material unreacted.
Table 1. Solvent effect on selective acylation of resveratrol
Substrate

Acyl Source

Base

Solvent

3 : 4'

Resveratrol

3 eq. AcCl

3 eq. Pyridine

DCM

Tri-AR

Resveratrol

1 eq. Ac2O

3 eq. NaOH

H2O

1.2 : 1.0

Resveratrol

1 eq. Ac2O

1.1 eq. K2CO3

EtOH

1.3 : 1.0

Resveratrol

1.2 eq. Ac2O

2.2 eq. K2CO3

Acetone

1.0 : 4.6

Resveratrol

1.5 eq. Ac2O

1.3 eq. NaH

THF

1.0 : 5.0

Due to possible anion scrambling mentioned above, concentration of the reaction was
addressed next. Identical conditions of 1.5 equivalents Ac2O and 1.5 equivalents NaH in THF
were performed with 50 mg of resveratrol. The two concentrations investigated were 8.7 mM
and 220 mM. Despite being significantly different concentrations, there was no difference in
selectivity for mono-ester formation.
The next component optimized was the base used to deprotonate resveratrol. Initial use
of K2CO3 yielded good results (Table 2). Due to the low pKa of its conjugate acid, reversible
deprotonation occurred to some extent giving appreciable amounts of di- and triacetylresveratrol.
Using NaH allowed for complete deprotonation giving a slightly larger conversion of starting
material to esterified product. No significant benefit was seen when using a stronger base such
as n-BuLi. Et3N was also used in DMSO and was found to give similar results to NaH in THF.
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Table 2. Base effect on selective acylation of resveratrol
Substrate

Acyl Source

Base

Solvent

3 : 4' : Res

Resveratrol

1.5 eq. Ac2O

1.1 eq. n-BuLi

THF

1.0 : 4.4 : 3.6

Resveratrol

1.5 eq. Ac2O

1.1 eq. NaH

THF

1.0 : 5.0 : 3.2

Resveratrol

1.5 eq. Ac2O

3 eq K2CO3

Acetone

1.0 : 4.6 : 2.9

Due to the reversible nature of possible anion formation, variations in reaction
temperature were explored. The 4’-phenolate anion has the lowest pKa (8.9) due to extended
conjugation across the stilbene skeleton.25 This led us to believe that this anion proceeds through
a thermodynamic pathway to the desired product. The 3 and 5 phenolate anions do not benefit
from the same conjugation as the 4’ anion. The 3 and 5 hydroxyls have pKa slightly higher at
10. Although having a higher pKa disfavors anion formation over the 4’ phenolate due to
electronic factors, there is a higher probability, 2:1, that deprotonation would occur at the 3 or 5
position. This favors product formation through a kinetic pathway. Thus, there is competition
between forming the more stable anion versus the statistically more probable anion.
Table 3. Temperature effect on selective acylation of resveratrol in THF
Substrate

Acyl Source

Base

Temperature °C

3 : 4' : Res

Resveratrol

1.5 eq. Ac2O

1 eq. NaH

-78

1.0 : 2.9 : 3.9

Resveratrol

1.5 eq. Ac2O

2 eq. NaH

0

1.0 : 4.0 : 2.9

Resveratrol

*1.5/1.5 eq. Ac2O

*1/1 eq. NaH

25

1.0 : 4.3 : 2.3

Resveratrol

1.5 eq. Ac2O

1 eq. NaH

50

1.0 : 5.0 : 3.2

Resveratrol
1.5 eq. Ac2O
1.1 eq. NaH
65
1.0 : 5.0 : 1.9
*1 eq. NaH and 1.5 eq. Ac2O were added followed by a second iteration after 30 minutes.
Optimized reaction conditions using NaH and Ac2O in THF were subjected to various
temperatures to assess both the optimal temperature for maximum 4’-acetate formation and to
test our hypothesis (Table 3). Performing the reaction at room temperature gave the previously
mentioned ratio of 3 to 4’ acetates and resveratrol at 1.0:4.3:2.3 respectively. Cooling the
11

reaction down to 0° C produced essentially the same ratio with slightly less starting material
being converted. At –78° C the reaction gave much lower conversion and less selectivity for the
4’ ester with a ratio of 1.0:2.9:3.9. This seemed to agree with our theory that kinetic conditions
would favor formation of the 3-acetate as seen by the decrease of 4’-acetate formation. The
reaction was then performed at 50° C. This increased selectivity for the 4’-acetate, but left
similar amounts of unreacted starting material. A final attempt at 65° C in THF not only
maintained the selectivity for the 4’-acetate, but also greatly improved the conversion of starting
material to the desired product. The observed trends seem to indicate that the 4’-phenolate does
indeed lead to a thermodynamic product, 4’-acetate, whereas the 3-phenolate gives the kinetic
product, 3-acetate.
Other polar aprotic solvents were explored since this factor seemed to have the largest
impact observed in our reaction system. DMSO yielded the best results using our optimized
conditions of warm temperature with NaH and acetic anhydride (Table 4). In fact, heating the
reaction was found to be unnecessary to maintain high selectivity and conversion of starting
material. Final conditions of NaH in DMSO gave 4’-pivaloylresveratrol 4 (58%), 4’acetylresveratrol 7 (47%), 4’-n-butyrylresveratrol 8 (46%), and 4’-iso-butyrylresveratrol 9 (43%)
in modest yields. Use of K2CO3 in DMSO also gave an acceptable yield of 4’-benzoylresveratrol
6 (32%) using benzoyl chloride as the acylating agent.
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Table 4. Monoesterification of resveratrol in DMSO
Substrate

Acyl Source

Base

Product

Yield %

Resveratrol

1.5 eq. Ac2O

1.5 eq. Et3N

4'-acetylresveratrol

47

Resveratrol

1.5 eq. (i-PrCO)2O

1.5 eq. NaH

4'-iso-butyrylresveratrol

43

Resveratrol

1.5 eq. (n-PrCO)2O

1.5 eq. NaH

4'-butyrylresveratrol

46

Resveratrol

1.5 eq. (t-BuCO)2O

1.5 eq. NaH

4'-pivaloylresveratrol

58

Resveratrol

1.5 eq. PhCOCl

1.5 eq. K2CO3

4'-benzoylresveratrol

32

1.2.2

Assessing Anti-cancer Activity of Resveratrol Analogues
Seven analogues of resveratrol were tested to determine their anti-cancer activity against

two cell lines. The seven analogues tested consisted of 4’-ester analogues with one 3,4’-difluoro
resveratrol analogue previously reported by Andrus4 et. al. The two cell lines were DU-145 and
SNU-16 which corresponds to human prostate and stomach cancer respectively.
Standard solutions of each analogue were prepared in DMSO to give a 30 mM
concentration. These solutions were then given to Wasatch Scientific for analysis of anti-cancer
activity. Dilutions were made to obtain 100, 30, 10, 3, 1, 0.3, 0.1, and 0.03 μM solutions. The
cells were plated out using an ATP-lite (Perkin Elmer) method. After treating the cell cultures
for 72 hours, analysis of the samples was made using an Envision (Perkin Elmer) instrument to
determine IC50 values for each analogue. After fitting the data for each compound, the IC50
values shown in Figure 8 were reported by Wasatch Scientific.
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Figure 8. IC50 values of resveratrol and resveratrol analogues in μM
Resveratrol showed good activity having IC50 values of 12.4 μM for DU-145 cells and
4.7 μM for SNU-16 cells. Most of the analogues had comparable activity with resveratrol.
Given the experimental error for each compound, the reported values are not statistically
different. This indicates that the esters likely act as pro-drugs and rapidly convert to resveratrol
once absorption has occurred.
1.3 Conclusion and Future Work
Resveratrol has been isolated and synthesized by several methods. Most recently it has
been synthesized by Andrus et. al. in four steps. This route allowed for selective
functionalization of each phenol to produce various ester analogues of resveratrol. Two new 4’ester analogues have been synthesized including 4’-pivaloylresveratrol 4 and 4’benzoylresveratrol 6. Other ester analogues can be easily accessed using other anhydrides or
acid chlorides as the acylating agent with intermediate 1.
14

Another route to 4’-ester analogues of resveratrol has also been disclosed. Resveratrol
can be directly esterified under basic conditions with various anhydrides. The issue of selectivity
between esterification of resveratrol on the 3- or 4’-hydroxyl was determined to be governed
primarily by the nature of the solvent. Other factors having a significant effect on selectivity
were the choice of base and temperature of the acylation reaction. The other issue overcome by
this work was controlling mono-esterification over di- or tri-esterification. By carefully
controlling the equivalents and rate of anhydride addition to the reaction, primarily monoesterfication could be achieved. Monoacylated 4’- products were produced in high purity and
modest yield. Due to some amount of di- and tri-esterification, there was always some amount
of unreacted starting material present when the reaction was quenched. This starting material
could easily be isolated and subjected to the reported conditions to generate more of the 4’-ester
resveratrol analogue. Optimal conditions for 4’-ester resveratrol analogue formation were found
to be use of 1.5 equivalents NaH and 1.5 equivalents anhydride at 65° C for one hour in DMSO.
This combination was arrived at after extensive investigation varying all of the above mentioned
parameters.
Testing of resveratrol, the two newly synthesized 4’-ester analogues, and four other
analogues previously synthesized by Andrus et. al. was carried out with prostate and stomach
human cancer cell lines. These findings show that esterification of the 4’-hydroxyl of resveratrol
does not increase the effectiveness of this polyphenol towards these cell lines. However, other
properties are likely enhanced such as stability and absorption. Other 4’-ester and 4’-amide
analogues of resveratrol can now be pursued in future work to determine other possible drug
candidates with increased stability to metabolic pathways as well as increased anti-cancer
activity.
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2. Selective Oxidation using Chromium Trioxide
2.1 Introduction
Chemistry revolves around reactive functional groups. Typically alkyl chains in
molecules are looked at as supporting structures for the reactive areas of molecules. These nonreactive areas are routinely modified in organisms using enzymes to catalyze functionalization
and therefore introduce typical reactive sites.26 We can potentially open more efficient routes to
synthetic targets by developing reagents that allow chemists to view these aliphatic groups as
more than just inert scaffolding.
Recently several research groups have been able to develop oxidation methods targeting
both activated and unactivated C–H bonds. Aside from using enzymes, typical reagents used to
afford the desired oxidation rely on metal catalysts.
C–H bonds can be electronically activated by neighboring alkene or aromatic groups.
Oxidation at allylic positions has been accomplished with several reagents. Selenium dioxide is
known to be the most reliable oxidant for allylic oxidation. Mann27 et. al. reported the use of
selenium dioxide in both stoichiometric and catalytic amounts. When selenium dioxide is used
as the oxidant several organoselenium byproducts are formed from the reduced selenium species
reacting with the alkene substrate. Reduced selenium also makes purification of the desired
product difficult. Use of hydrogen peroxide as a cooxidant is known to give diols and epoxide
products instead of the desired allylic oxidation. However, these reaction conditions do
accomplish the desired transformation with β-pinene with high efficiency using catalytic
selenium dioxide (Figure 9). This inspired Mann et. al. to investigate other peroxides as
cooxidants. Tert-butyl hydroperoxide was found to be ideal proceeding with only 2% catalyst
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loading while maintaining similar or slightly improved yields for the allylic alcohol. This
allowed for reduced byproducts and a simplified isolation procedure.

Figure 9. Allylic oxidation with catalytic SeO2
White28 et. al. published a method using palladium(II) acetate with a bis-sulfoxide ligand
to yield both branched and linear allylic oxidation of terminal alkenes. Typically use of
palladium(II) catalysts in this manner result in Wacker oxidation products when used with
terminal alkenes. However, when the reaction was carried out in DMSO there was a shift in
selectivity to give predominately the linear allylic acetate oxidation product (Figure 10). After
further investigation, the bis-sulfoxide ligand was designed due to the belief that the sulfoxide
was coordinating the palladium catalyst and inducing a charged intermediate in the catalytic
cycle altering the mechanism of action. When the terminal alkene substrates were subjected to
the new palladium(II) bis-sulfoxide ligand complex almost exclusive linear allylic oxidation
products were observed. Selectivity for the linear oxidation product was inverted to give the
branched allylic acetate when the solvent was exchanged for other polar organic solvents. The
scope for this new palladium catalyst was shown to be much larger and selective for allylic
oxidation than other previously reported catalysts.
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Figure 10. Linear and branched allylic oxidation with Pd(OAc)2
Directed oxidation has also been used to produce desired oxidation products when the
substrate was lacking proper electronic activation from adjacent π systems. These isolated areas
require the reactive species to be brought within close proximity to allow the oxidation to occur.
Desai29 et. al. described in 2004 a method of oxidizing methyl groups beta to chelating
oximes with a palladium catalyst. The oxidant used for this transformation was PhI(OAc)2.
Initial chelation of the palladium catalyst by the oxime allows direct access to adjacent methyl
groups for oxidation (Figure 11). This procedure improves upon previous efforts by increasing
the scope of substrates that can be oxidized. This method still has limitations. There is only one
example of non-methyl oxidation reported. Oxidation of β–methylene C–H bonds worked in one
instance and there are no substrates listed involving methine carbon hydrogen bonds. However,
the selectivity for a single oxidation product is high making this process an excellent method for
specific applications.
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Figure 11. Directed oxidation by oxime coordination of palladium(II) acetate
Recent advances in oxidizing tertiary and secondary C–H bonds have been made by
White30 et. al. using an Fe(S,S)-PDP catalyst (Figure 12). The natural product (+)-artemisinin
contains five tertiary C–H bonds which differ from each other slightly electronically and in steric
hindrance. Through preliminary investigations on model substrates it was predicted that their
iron catalyst would selectively oxidize one of the five tertiary C–H bonds. It was both less
hindered sterically and electron rich. Much to White’s delight it proceeded giving a 54% yield in
1.5 hours which compared to an enzymatic process using C. echinulata yielded only 47% after
four days of reaction time. It was widely demonstrated that application of the iron catalyst in
AcOH and H2O2 could easily and selectively oxidize unactivated methine C–H bonds.31

Figure 12. Selective methylyne oxidation using Fe(S,S)-PDP catalyst
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Secondary C–H bonds are challenging targets for oxidation. Electronics and sterics are
the two controlling factors for selectivity in oxidizing substrates. Secondary C–H bonds lie in
the middle of these two trends making them difficult to select for over other C–H bonds in the
compounds being oxidized. However, White’s Fe(S,S)-PDP catalyst was also tailored to achieve
selective methylene oxidations to give ketone products (Figure 13). When linear substrates
bearing a terminal methyl ester were subjected to conditions reported by White32 et. al., a
mixture of oxidation products was produced. The electron withdrawing effect contributed by the
methyl esters predominately controlled selectivity for oxidation. Ketone formation was favored
at the most distal methylene from the methyl ester. Slightly different selectivity was observed
when substrates were switched to cyclic compounds. Oxidation would occur in six membered
rings at the meta rather than para methylene in order to relieve torsional ring strain. Yields for
these oxidations were reported to be between 30-50% leaving some room for future
improvement.

Figure 13. Selective methylene oxidation using Fe(S,S)-PDP catalyst
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A previous report by Money33 et. al. specifically examined oxidation of (–)-bornyl
acetate (Figure 14). There are several reports in the literature for terpene oxidation of the C5
carbon. Use of chromium trioxide in boiling acetic acid yields 35–45% of 5-oxobornyl acetate
after two hours. There are other minor oxidation products including 6-oxobornyl acetate (10–
13%), 5-exo-acetoxybornyl acetate (2–3%), and 3-oxobornyl acetate (1–3%) which are difficult
to separate. This example of methylene oxidation was only investigated with a few terpene
compounds including isobornyl acetate and camphor. Meinwald34 et. al. also produced 5oxobornyl acetate as an intermediate in the synthesis of (+)-epi-β-necrodol. Chromium trioxide
was used to produce the oxidized intermediate 5-oxobornyl acetate from (–)-bornyl acetate.
Further oxidation using selenium dioxide gave diketone 5,6-dioxobornylacetate. Chromium
trioxide could prove to be a valuable oxidant if selectivity and yields could be improved.

Figure 14. Oxidation of (–)-bornyl acetate with chromium trioxide
2.2 Results and Discussion
2.2.1

Oxidation Conditions
Oxidation of terpene structures at C5 have been reported in the literature with poor to

moderate yields. This oxidation is necessary for producing mimics of (–)-englerin A (see
chapter 3). This desired oxidation was attempted with various conditions reported in the
literature using (–)-bornyl acetate as the substrate. Most of procedures described below were
previously used to achieve allylic and benzylic oxidations.
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Methyl(trifluoromethyl)dioxirane (TFDO) has been used by Curci35 et. al. to oxidize
secondary and tertiary C–H bonds to corresponding ketones and alcohols.35,36 Conditions have
also been reported to form epoxides from various olefins using TFDO.37 Formation of the
oxidant is a somewhat complicated process and the resulting TFDO must be used immediately
due to is highly reactive nature. This process was simplified by Yip37 et. al. in a procedure that
generates TFDO in situ using 1,1,1-trifluoroacetone with a mixture of NaHCO3 and Oxone. We
hoped that the desired methylene oxidation would occur on (–)-bornyl acetate 10 to give 11.
when these conditions were applied (Figure 15). However, there was no conversion of bornyl
acetate to any other compounds. This is likely due to the difficulty in forming the oxidant even
when using the in situ procedure.

Figure 15. TFDO oxidation of norbornane and (–)-bornyl acetate 10
NaIO4 has been used by Koo38 et. al. to oxidize carotenoid compounds to access natural
products including canthaxanthin, astaxanthin, and astacene. Oxidation was seen at allylic
methylene carbons to give the related α,β-unsaturated ketones (Figure 16). When we treated (–)bornyl acetate 10 with the initial three equivalents of NaIO4, a small conversion to product was
observed by TLC in 10% EtOAc/Hex. After 40 hours the reaction was worked up to give less
than 5% yield of the desired ketone product 11. Due to the low conversion of starting material,
other oxidation conditions were explored.
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Figure 16. NaIO4 oxidation of canthaxanthin intermediate and (–)-bornyl acetate 10
Allylic and benzylic oxidations have also been accomplished with NaClO2. When
coupled with cooxidant tert-butyl hydroperoxide, excellent yields were obtained for a large
variety of substrates.39 Although all reported examples oxidize at an activated methylene carbon
to give the desired ketone, oxidation of less activated methylene groups might be possible
(Figure 17). We subjected (–)-Bornyl acetate 10 to NaClO2 and t-butyl hydroperoxide in a
mixture of CH3CN/H2O. After 18 hours, some conversion to the desired ketone 11 was observed
by TLC. After workup there was less than a 10% yield prompting further exploration of other
conditions.

Figure 17. NaClO2 oxidation of dehydroepiandrosterone and (–)-bornyl acetate 10
In an effort to improve upon the yield for converting 10 to 11, additional metal catalysts
were investigated including rhodium, palladium, and chromium. Each metal has published
reports describing their ability to catalyze the oxidation of both activated and unactivated C–H
bonds. Due to the large quantity of various conditions reported, only one or two conditions were
investigated for each metal using 10 as our model substrate.
The rhodium dimer catalyst, dirhodium(II) caprolactamate (Rh2(cap)4), has been shown
to be effective for allylic oxidation.40 Cyclohexene when treated with 0.1 mmol catalyst for 1
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hour gave a 60% yield of the desired cyclohexenone (Figure 18). Other related cyclic alkenes
were converted with comparable yields ranging from 70–94%. TBHP was used as a cooxidant to
regenerate the rhodium catalyst after initial oxidation of the substrate. When we applied these
conditions to (–)-bornyl acetate 10, no product was observed and all starting material was
recovered.

Figure 18. Rh2(cap)4 oxidation of cyclohexene and (–)-bornyl acetate 10
Palladium hydroxide (Pd(OH)2) was also shown to be an effective catalyst for converting
both cyclic and linear enones to their corresponding γ-ketoenones (Figure 19). When treated
with 5 mol % Pd(OH)2/C, 5 equivalents TBHP, and 0.5 equivalents K2CO3 in DCM, the desired
products were obtained in yields of 79–90%.41 This method requires a very activated C–H to
undergo oxidation so expectations were low for successful conversion of (–)-bornyl acetate 10 to
the desired ketone 11. Indeed, after we exposed 10 to the described conditions for 24 hours there
was no conversion to product.

Figure 19. Pd(OH)2 oxidation of acetylcyclopentene and (–)-bornyl acetate 10
Similar results were obtained when using Pd(OAc)2 conditions reported by Chen42 et. al.
This method differs from other previously attempted oxidation methods by directly

24

functionalizing an unactivated C–H bond (Figure 20). This was accomplished by using a
picolinamide directing group that could coordinate the metal catalyst positioning it to oxidize the
desired C–H bond. Substrates explored were primarily alkyl with a β-methyl group. The
targeted C–H bond on the methyl group can be oxidized to various ethers with the appropriate
alcohol. Many of the reported examples were able to form methyl ethers with various
picolinamides, but the example most valuable to our synthetic route would be benzyl ether
formation. There were two reported examples showing both alkyl insertion to a β-methyl C–H
bond and an aryl ortho-C–H bond. If this alcohol could successfully be inserted then benzyl
protection of the alcohol would already be achieved. We converted borneol to the picolinic ester
12 and then subjected to Pd(OAc)2, PhI(OAc)2, and BnOH in p-xylene for 4 hours. TLC in 10%
EtOAc/Hex revealed many oxidation products. The major product was determined to be the
benzyl ether of the bridgehead methyl C–H bond. However, none of the oxidized compounds
were the desired product.

Figure 20. Pd(OAc)2 oxidation using picolinic acid as a directing group
Some success was finally obtained when conditions reported by White31,32 et. al. were
employed. These conditions utilized an iron catalyst with (2S,2'S)-1,1'-bis(pyridin-2-ylmethyl)2,2'-bipyrrolidine (PDP) ligand. This catalyst was reported to selectively oxidize secondary C–H
bonds over primary and tertiary (Figure 21). Most substrates explored contained either ketone or
ester functional groups which seemed to influence the location of oxidation. Oxidation typically
occurred with highest frequency at the methylene carbon furthest from the electron withdrawing
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group. This equates to oxidizing the most electron rich methylene carbon due to the electron
withdrawal of the ester or ketone functionality. Other minor oxidation products were observed at
more proximal methylene carbons. When we applied the described method to (–)-bornyl acetate,
the desired product was observed by TLC in 10% EtOAc/Hex. After workup, an 18% yield was
obtained with only one other minor oxidation product observed. Although a promising result,
the yield was much too low to produce enough intermediate needed for our synthetic route to
englerin A mimics. Hopes of improving the yield using this method was not likely due to the
isolated yield being comparable to those reported by White et. al. The cost of the catalyst also
made this method impractical for scale up.

Figure 21. Fe(S,S)-PDP oxidation of cycloheptyl pivalate and (–)-bornyl acetate 10
The last metal investigated for conversion of 10 to 11 was chromium. Conditions using
TBHP and pyridinium dichromate (PCC) were first tried as reported by Chandrasekaran43 et. al.
(Figure 22). These conditions were applied to many compounds to accomplish both allylic and
benzylic oxidations by Chandrasekaran’s group. Pinene is structurally related to (–)-bornyl
acetate 10 and was one of the many substrates that was oxidized successfully with these
conditions. However, when we treated (–)-bornyl acetate 10 with the above conditions, there
was only a small conversion to product giving less than 5% yield of 11 after purification.
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Figure 22. PCC oxidation of pinene and (–)-bornyl acetate 10
The last conditions attempted were reported by Money33 et. al. CrO3 in AcOH at reflux
was capable of oxidizing (–)-bornyl acetate 10 to give both acetate and ketone functional groups.
Attempts to reproduce these results were met with some success. We were able to obtain initial
yields of 25% with two other product spots visible by TLC in 10% EtOAc/Hex. The procedure
specifies dissolving the starting material in AcOH and heating to reflux at 115° C. 4 equivalents
of CrO3 is then dissolved in 4–5 mL of AcOH and added dropwise over the period of an hour to
the reaction flask. It was found that the rate of addition of the CrO3 solution had a large impact
on the yield of the reaction. The slower the CrO3 was added the better the overall yield of 11.
By increasing the addition time to 90 minutes, the yield was boosted to the reported 40%.
Further attempts to optimize these conditions were made by adding additional equivalents of
CrO3. After adding the first 3.5 equivalents of CrO3 over 90 minutes, the reaction was allowed
to stir for one hour and then a second 3.5 eqivalents of CrO3 was added. This second addition of
CrO3 was able to increase the yield even further to 70%. All starting material was consumed at
this point. With the above mentioned optimization of the CrO3 conditions, this procedure was
applied to all englerin A mimic routes to give oxidation of (–)-bornyl acetate 10 (69%), (+)bornyl acetate 14 (70%), and (+)-fenchyl acetate 16 (40%) in good to reasonable isolated yields
(Table 5). The lower yield for fenchyl acetate 16 is believed to be the result of the increased
steric hindrance imposed by the methyl groups being adjacent to the acetate functionality.
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Table 5. Various norbornanes subjected to
3.5/3.5 eq. CrO 3 in ref luxing AcOH f or 5 hous
Substrate

Product

Yield

69%
O

10

11

OAc

OAc

70%
AcO

AcO

14

15 O

O

40%
16

OAc

17

OAc

2.2.2 CrO3 Oxidation Mechanism
With no specific mechanism reported for the oxidation using CrO3, an attempt was made
to determine whether the acetate group was directing the oxidative insertion of the catalyst.
There are a few commonly used directing groups that are known to coordinate metal catalysts
and promote oxidative insertions that otherwise would not proceed.
Both 2-picolinic acid and 1H-pyrrazol-3-carboxylic acid were used to esterify (–)borneol. It was proposed that these esters would more efficiently coordinate the CrO3 catalyst
and thereby improve the level of oxidative insertion leading to the desired oxidation product.
Both 12 and 18 were subjected to the original oxidation conditions reported by Money33 et. al. to
assess any improved reactivity. In both cases, there was no oxidation of the prepared esters.
This led to the conclusion that the acetate ester did not serve as a directing group for the CrO3.
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Instead, when other more efficient directing groups were used, the reaction was shut down.
There are two logical reasons for these results. The first reason is that the directing groups did
coordinate the metal catalyst, but were unable to deliver the catalyst to the desired oxidation site.
This coordination led to an inactivation of the reaction by preventing the insertion of the metal
catalyst. The second reason is likely due to the change in the electronic properties of the
molecule. By replacing the acetate ester with an aryl ester, the electronics of the target
methylene carbon could have been affected making insertion less favorable.

Table 6. Picolinic acid and 1H-pyrazole5-carboxylic acid directing groups f or
CrO3 oxidation of (-)-borneol
1) RCOCl, pyr
2) 4 eq CrO3
OH

AcOH

R group

O
OR

Yield

O

40%
O

10
N

O

< 5%

12
< 5%

N
NH

18
A proposed mechanism for oxidation with CrO3 is shown in Figure 23. Direct oxidative
insertion of CrO3 into the C–H bond allows formation of a chromate ester intermediate. After
insertion, deprotonation of the α-hydrogen by acetate gives the desired ketone. Some alcohol
product is possible if any amount of H2O is present to hydrolyze the chromate ester intermediate

29

before deprotonation occurs. Indeed, an example of oxidation to the alcohol in addition to the
ketone was reported by Money33 et. al. confirming the possibility of this intermediate.
AcO
H

H
O
Cr
O

OAc

H
O

[3+2]

O

O

OAc

O

Cr
OH

Figure 23. The proposed mechanism for direct insertion of CrO3 with (–)-bornyl acetate
2.3 Conclusion and Future Work
Selective oxidation of complex small molecules has been explored recently by several
research groups with great success. Oxidation of primary, secondary, and tertiary C–H bonds
have all been met with some degree of success. Secondary C–H bonds have proved most
difficult giving the lowest yields and narrowest scope of substrates.
Oxidation of the C5 carbon of (–)-bornyl acetate 10 has been reported by Money et. al.
with CrO3 in 40 % yield. Other oxidation conditions were explored to achieve this same
oxidation by employing various oxidants and metal catalysts. However, the chosen conditions
yielded little to no favorable results.
Non-metal oxidants tried included TFDO, NaIO4, and NaClO2. These oxidants showed
positive results in oxidizing allylic and benzylic methylene carbons as reported in the literature.
However, when applied to (–)-bornyl acetate 10 there was always less than a 5 % yield obtained.
Metal catalysts Pd(OH)2, Pd(OAc)2, Rh2(cap)4 when coupled with peroxides or
PhI(OAc)2 managed allylic, benzylic, and directed oxidation of primary C–H bonds using
picolinic acid as the directing group. These conditions were equally unsuccessful in providing
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the desired 5-oxobornyl acetate. In all cases, the starting material was recovered with the
exception of Pd(OAc)2 which yielded several oxidized compounds none of which were the
desired product. The Fe(S,S)-PDP catalyst developed by White32 et. al. was able to catalyze the
desired reaction to give 5-oxobornyl acetate 11 in 39 % yield. This yield was comparable to
using CrO3 in acetic acid which also gave a 40 % yield. Due to the high cost of the iron catalyst,
the chromium conditions were examined and optimized for (–)-bornyl acetate 10 to achieve a 70
% yield of the desired product. Other substrates examined were (+)-bornyl acetate 14 (69 %)
and (+)-fenchyl acetate 16 (40 %). These particular terpene substrates can be used to complete
the synthesis of (–)-englerin A mimics proposed in chapter 3. Expanding the scope of this
reaction further by investigating other substrates for oxidation could yield other useful
compounds for use in synthesis.
The mechanism of oxidation using CrO3 was also examined by producing various esters
of (–)-borneol with common directing groups such as picolinic acid. These directing groups
caused a significant decrease in the yield when subjected to conditions reported by Money et. al.
It is hypothesized that the coordinating ester groups prevented the metal from inserting and
oxidizing the bornyl ester. The additional functionality introduced also provides new oxidation
sites that could be more prone to oxidative insertion than the desired C–H bond. It is proposed
that oxidative insertion proceeds directly through a [3+2] addition to form a chromate ester
intermediate. Deprotonation then leads to the desired ketone. Other esters could be explored
which would significantly alter the electronics of the borneol core such as pivalate and isobutyrate esters. These bulkier esters would yield additional information on how the approach of
CrO3 to the borneol core was governed.
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3. (–)-Englerin A Mimic Synthesis and Anti-cancer Evaluation
3.1 Introduction
3.1.1 Discovery
Englerin A is a guaiane sesquiterpene first
discovered by Ratnayaka44 et. al. in 2008. It was
isolated from the bark of Phyllanthus engleri, an
East African plant found in Tanzania and
Zimbabwe. The stem bark yielded 1.2 g/kg of
englerin A and the root bark yielded 2.4 g/kg. The
process for obtaining the purified compound from
the root bark involved initial extraction of ground
root bark with 1:1 (v/v) DCM : MeOH overnight. The resulting extract was then coated onto
diol bonded phase media and eluted with hexane, methylene chloride, ethyl acetate, acetone, and
methanol. Each fraction was tested against A498 or UO-31 (renal cancer) and SF-295 (CNS
cancer) cell lines to determine activity. The methylene chloride fraction was the only one
possessing activity towards the cell lines evaluated. A silica gel column eluted with chloroformmethanol isolated compounds englerin A and B from all other components of the crude fraction.
Final purification by HPLC gave pure englerin A and englerin B. Englerin A and B structure
differ only slightly with englerin B lacking a glycolate ester (Figure 24). The structure of
englerin A exhibits a relatively non-polar core with two polar ester side chains. Other related
compounds have been previously reported by Hikino45,46 et. al. in 1966.
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3.1.2 Biological Activity
Englerin A and B were screened against the NCI-60 cell panel in which englerin A
showed selectivity for renal cancer cell lines. GI50 (growth inhibition of 50 % of cells) values for
five of the eight renal cell lines were less than 20 nM. These cell lines were 786-0, A498,
ACHN, CAKI-1, and UO-31. Englerin B had drastically reduced activity suggesting that the
glycolate ester plays a significant role in the observed anti-cancer activity.44
The mechanism of action for englerin A was recently reported on by Neckers47 et. al. It
was shown that englerin A activates protein kinase C θ (PKCθ). PKCθ then initiates two
different biological processes within the cell. The first process induces an insulin-resistant
phenotype by phosphorylating insulin receptor substrate 1 (IRS1). This phosphorylation causes
IRS1 to dissociate from the insulin receptor. The phosphorylated IRS1 then reduces PI3K/AKT
signaling causing the cell to reduce glucose uptake. The second process starts with PKCθ
mediating the phosphorylation of heat shock factor 1 (HSF1). Phosphorylated HSF1 acts as a
transcription factor that enforces tumor cell glucose dependence. These two processes act
synergistically to starve the cancer cell of needed energy by reducing uptake of glucose and
enforcing glucose dependence. This result supports the previously published anti-cancer activity
of englerin A due its cytotoxicity towards glycolytic tumor cells.
3.1.3 Total Synthesis of Englerin A
Due to its unique activity profile, a total synthesis of englerin A has been eagerly
pursued. There have been seven total synthesis reports of englerin A to date. Synthetic routes
range from 18–25 steps with one very efficient synthesis consisting of only eight steps.48–56 All
synthetic routes have a low overall yield making production for treatment use cost prohibitive
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except for the route reported by Chain48 et. al. which accomplished the total synthesis with a
20% overall yield.
The first reported synthesis of englerin A by Christmann49 et. al. resulted in production of
the natural product’s enantiomer, (+)-englerin A. This allowed for the exact identification of
englerin A’s structure and absolute configuration. The first total synthesis of (–)-englerin A was
reported in the same journal issue as the second total synthesis. Both Ma50 et. al. and
Echavarren51 et. al. published back to back synthetic routes to (–)-englerin A. Ma used
commercially available (R)-citronellal and completed the synthesis with the use of no protecting
groups. Echavarren employed (E)-3,7-dimethylocta-2,6-dien-1-ol and completed his route in 18
steps with an overall yield of 13.3%. This is the shortest route reported to date with one of the
higher overall yields.
A third synthesis of (–)-englerin A was reported later in 2010 by Nicolaou52 et. al. The
route was completed in 22 steps starting with 7-(benzyloxy)hept-2-yn-1-ol. This route utilized a
few of the later synthetic steps published by the preceding groups. This route was both longer
stepwise and resulted in a racemic mixture of the desired englerin A. An asymmetric method
was explored, but still gave a mixture of 1:2 of the englerin A enantiomers.
The most efficient synthesis of (–)-englerin A reported by Chain48 et. al. gave a 20%
overall yield in 8 steps from 3-furanone and 5-methylcyclopentenecaboxaldehyde. The key to
Chain’s success was the use of SmI2 to couple the two starting materials together after an initial
Michael addition. This afforded the core of (–)-englerin A after only 4 steps. Installation of the
ester side chains was then a simple matter to complete the natural product.
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3.1.4 Mimics of Natural Products
Many drugs that are currently on the market have been derived from natural products
isolated from nature. Chemical modifications are typically made on initial isolated structures to
improve their ADMET properties. Some examples of truncated or modified natural product
drugs are halichondrin, bryostatin, spongistatin, and bistramide.57–61 This method of trying to
mimic the original compound is referred to as function-oriented synthesis (FOS). FOS puts
forward the idea that a molecule’s activity is based primarily on a subunit of the natural product.
Since compounds isolated from natural sources are not optimized for use in human systems, it is
very possible that portions of the original structure are not required to maintain the desired
activity.57
Synthetic routes to halichondrin B generally follow convergent methods to synthesize the natural
product.58 It was found that the right side subunit, when tested to determine cytotoxicity versus
several cancer cell lines, exhibited little to no activity. Derivatives were made varying the
location of disconnection to the left subunit of halichondrin B (Figure 25). Efforts yielded a few
promising structures with E7389 being highly active against several cancer strains. Thus
truncating natural products by removing unnecessary components can simplify synthesis and
maintain desired activity.59
H
H
HO
HO

HO

O
O

H

H

H

O
O

H

O

H

H

H2N

O
O

O
O

O
H
O O

HO
O

H
O

H

OH O
O

O
O

O
O

Figure 25. Halochondrin B and Eribulin (E7389)
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Bryostatin is a complex and scarce natural product isolated from the marine bryozoan
Bulgula neritina (Figure 26).57 Isolation from natural sources required 14 tons of material to

yield 18 g of bryostatin. This allowed for initial clinical trials, but production levels required for
further research and commercialization leaves biosynthetic routes the only possible alternative to
access significant amounts of bryostatin. Initial analysis of the bryostatin structure identified
several key functional groups that contribute to its activity. It was then proposed by Wender57 et.
al. that these essential sections be retained and pieced together using appropriate structural

linkers which would maintain approximate three-dimensional positioning of the conserved
sections. This method was then implemented to create a library of over 100 analogues. Thirty of
these analogues showed single digit nanomolar activity or lower to the targets of bryostatin. One
of these analogues is currently undergoing clinical trials for use in various diseases including
cancer treatment. The resulting mimics of bryostatin were able to maintain the activity initially
shown by bryostatin and create a realistic method to access large quantities of material making
supply a nonissue.

Figure 26. Bryostatin and a bryologue
(+)-Spongistatin is a macrocycle that was pursued by many research groups due to its
biological activity (Figure 27). Due to its complex structure, analogue synthesis is relatively
difficult. Smith60 et. al. reported a total synthesis of (+)-spongistatin and also proposed truncated
36

structures that could possibly maintain activity while simplifying the synthetic route. These
simplified molecules incorporated essential motifs of spongistatin as reported by other research
groups.62–65 The two spiroketals found in the original structure were replaced by appropriate
tethers to maintain the macrocycle. When both spiroketals were removed, there was minimal
activity. However, reinsertion of spiroketal AB into the truncated structure showed nanomolar
activity against target cancer cell lines. The design of these mimics was attempted with the hope
that maintaining the three-dimensional structure of the original compound would preserve
activity while allowing simplified structure substitutions to be incorporated.
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Figure 27. (+)-Spongistatin and ABEF-analogue
3.1.5 Englerin A Mimic Design
Englerin A was found to lose
its toxicity when both the glycolate
and cinnamate esters were removed
from the central core. In fact, if the
glycolate ester was modified at all,
then the activity of englerin was
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drastically reduced. Some variation was possible regarding the cinnamate ester although
analogues were very closely related to the cinnamate structure as reported by Christmann49 et. al.
(Figure 28). Several mimics were proposed in regards to the above mentioned observations.
The central non-polar core of englerin A could theoretically be replaced by a simplified nonpolar core that would still maintain three-dimensional positioning of the ester side chains. This
modification would greatly reduce the complexity of englerin A while hopefully maintaining the
desired anti-cancer activity. The proposed synthetic route to these targets is relatively short and
utilizes inexpensive starting materials in most cases.
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Figure 29. MacroModel root mean square deviation (RMSD) in Å and overlay
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The proposed mimic cores were chosen by calculating the low energy global minimum
energy for a mimic and then comparing its 3-D structure to englerin A (Figure 29). Calculations
were performed using MacroModel 9.1 with the MMFF force field (Schrödinger). Eight atoms
contained in the ester side-chains of each mimic were selected to determine their degree of
overlap with englerin A. The degree of correlation was determined by calculating a root mean
squared deviation of the distances between the chosen ester atoms. The closer to zero this
number is, the greater correlation between the mimic and natural product. The initial proposed
cores included cyclohexyl, (+)-bornyl 19, (+)-fenchyl 20, and bridged cycloheptyl structures.
The retrosynthesis for the proposed (–)-bornyl mimic begins by disconnecting the
glycolate ester side-chain (Figure 30). The alcohol would be protected as a silyl ether to allow
for addition of the cinnamate ester selectively to the second alcohol. The second alcohol will
have been previously protected with an acetate group which allows the installment of the remote
alcohol functionality by way of selective oxidation of the desired methylene carbon to the ketone
followed by reduction with NaBH4. The resulting acetate ester of (–)-borneol is commercially
available from Sigma Aldrich at a reasonable price of $23.80 for 5 g. The other proposed
mimics follow the same prescribed route by substituting (+)-borneol or (+)-fenchol as the
starting material.
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Figure 30. Retrosynthesis of (–)-borneol mimic 21
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3.2 Results and Discussion
The first mimic pursued uses (–)-bornyl acetate as the starting material. This core was
chosen first due to its relatively low cost compared to other proposed cores. Since (–)-borneol
was commercially available as the acetate ester 10, oxidation conditions of CrO3 in acetic acid
were applied to give ketone 11 in 70% yield (Figure 31). Selective reduction of ketone 11 using
NaBH4 and Lewis acid CeCl3·7H2O gave the exo alcohol 11a in 67% yield. This reduction
proceeded selectively due to the steric hindrance of the two methyl groups on top of the bornyl
core blocking the approach of the NaBH4 from the top face. The resulting alcohol 11a was then
protected with TBSCl and imidazole to give a quantitative yield of the silyl ether 23. Reduction
with DIBAL to remove the acetate ester of 23 proceeded smoothly to give alcohol 23a in 99%
yield. Addition of the first ester using cinnamoyl chloride with pyridine gave the cinnamate ester
22 in 45% yield. Proceeding on with removal of the TBS group with TBAF gave alcohol 22a in
92% yield after two days. Known acid chloride 24 was synthesized in three steps and used to
form the glycolate ester 22b in 13% yield. Following treatment with TBAF, the (–)-bornyl
mimic 21 of englerin A was isolated with a 42% yield.

Figure 31. Synthetic route to (–)-borneol mimic 21
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The (+)-bornyl mimic 19 was pursued next. This mimic overlays better with englerin A
than the (–)-bornyl mimic 21, but the starting material is approximately 20 times more expensive
than (–)-bornyl acetate 10. Since the route was worked out initially with the less expensive
enantiomer, we were confident that a significant amount of the (+)-bornyl mimic 19 could be
obtained following the same procedures.
(+)-Borneol 25 was first esterified with acetic anhydride and pyridine to give a 99% yield
of the desired acetate 14 (Figure 32). This intermediate was then subjected to CrO3 in acetic acid
at reflux to give ketone 15 in 70% yield. Selective reduction of ketone 15 was again
accomplished with NaBH4 and Lewis acid CeCl3·7H2O to give alcohol 26 with an improved
yield of 83%. Alcohol 26 was then protected with TBSCl and imidazole to give a quantitative
yield of the silyl ether 27. The acetate group of 27 was then removed by reduction using DIBAL
to give the corresponding alcohol 28 in 99% yield. Esterification using cinnamoyl chloride with
pyridine in DCM gave cinnamate ester 29 in a greatly improved yield of 83%. HF·pyridine was
utilized instead due to the long reaction time associated with removing the TBS protecting group
using TBAF in the (–)-bornyl mimic synthesis. After only two hours, HF·pyridine removed the
TBS group from 29 to give the associated alcohol 29a in 95% yield. As previously mentioned,
attemps to add the glycolate ester using the acid chloride 24 gave a low yield of 13%. In an
attempt to improve this yield, conditions reported by Yamaguchi66 et. al. were applied using
2,4,6-trichlorobenzoyl chloride and TBS protected glycolic acid 30. This formed the mixed
anhydride intermediate which was able to give the desired glycolate ester 29b in 30% yield
which was a slight improvement over the previous method. Final deprotection with HF·pyridine
gave the (+)-bornyl mimic 19 in 58% yield.
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Figure 32. Synthetic route to (+)-borneol mimic 19
The third mimic pursued contained a (+)-fenchol core which is a constitutional isomer of
the borneol cores. The synthesis of this mimic was revised from the originally proposed route
due to the inability to invert the initial alcohol stereocenter. (+)-Fenchol 31 was first esterified
with acetic anhydride and pyridine to give a 99% yield of the desired acetate 16 (Figure 33). The
acetate ester 16 was then subjected to CrO3 in acetic acid at reflux to give ketone 17 in 40%
yield. This yield was almost half of that observed with the borneol substrate. A possible
explanation for this decreased yield is that the two methyl groups that are now beta to the acetate
hinder the oxidative insertion due to increased sterics. Selective reduction of ketone 17 was
again accomplished with NaBH4 and Lewis acid CeCl3·7H2O to give alcohol 32 with a yield of

Figure 33. Synthetic route to (+)-fenchol mimic 20
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95%. Alcohol 32 was then protected with TESCl and imidazole to give a 99% yield of the silyl
ether 33. The acetate of 33 was then removed by reduction using DIBAL to give the
corresponding alcohol 34 in 71% yield. This slightly lower yield was likely the result of the
acetate being sandwiched between two quaternary carbons. This steric hindrance made the
approach of DIBAL difficult and increased reduction of the silyl ether to give undesired side
products. Oxidation of alcohol 34 was then performed using TPAP and NMO to give a 99%
yield of the desired ketone 35. Efforts were then made to reduce ketone 35 to the exo position.
Birch reduction conditions using Li/NH3 were tried but resulted in 100% conversion to the endo
alcohol 34 (Figure 34). Meerwein-Ponndorf-Verley conditions were tried with i-propyl alcohol
and AlCl3, but no reaction occurred. A modified Mitsunobu reaction was also attempted using
chloroacetic acid and DIAD reagent; however, only starting material was recovered.

Figure 34. Efforts to reduce/invert C1 ketone/alcohol for (+)-fenchol mimic 20
Having tried several conditions to invert the stereochemistry of alcohol 34, it was decided
by our group to modify the design of the fenchyl mimic. Instead of inverting the stereochemistry
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of alcohol 34, 32 was treated with TBSCl and imidazole to give 33a. Reduction with DIBAL
gave alcohol 34a which could then be esterified using cinnamoyl chloride and pyridine in DCM
to give cinnamate ester 39 in 90% yield (Figure 35). HF·pyridine was used to remove the TBS
protecting group, but resulted in an unfortunate migration of the cinnamate ester to the
deprotected alcohol. This migration gave a significant amount of undesired product which
greatly reduced the yield of alcohol 40 to 52%. The glycolate ester was attached using the TBS
protected glycolic acid chloride procedure described in the synthesis of the (–)-bornyl mimic.
Fresh preparation of the glycolic acid chloride 24 was able to give the desired ester 41 at an
increased yield of 45% compared to the lower yield of 13% with the (–)-borneol mimic 19. Final
deprotection with HF·pyridine gave the (+)-fenchol mimic 42 in 60% yield. Although this
mimic fails to overlap well with englerin A, it would be valuable to know if only retention of the
ester side-chains was required for activity and 3-dimensional positioning was not as crucial.

Figure 35. Synthetic route to (+)-fenchol mimic 42
3.2.1 Assessing Anti-cancer Activity of Englerin A Mimics
The mimics of englerin A were tested to determine their anti-cancer activity against two
cell lines. Four compounds were tested which consisted of the (–)-borneol mimic 21,
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(+)-borneol mimic 19, (+)-fenchol mimic 20, and the aglycolate (+)-fenchol mimic 40. The two
cell lines were 786-0 and A498 which are both human kidney cancer cell lines.
Standard solutions of each mimic were prepared in DMSO to give a 30 mM
concentration. These solutions were then given to Wasatch Scientific for analysis of anti-cancer
activity. Dilutions were made to obtain 100, 30, 10, 3, 1, 0.3, 0.1, and 0.03 μM solutions. The
cells were plated out using an ATP-lite (Perkin Elmer) method. After treating the cell cultures
for 72 hours, analysis of the samples was made using an Envision (Perkin Elmer) instrument to
determine IC50 values for each mimic. After fitting the data for each compound, the IC50 values
shown in Figure 36 were reported by Wasatch Scientific.

Figure 36. IC50 values for (–)-englerin A mimics in μM. *Error values too wide.
The proposed mimic molecules of englerin A showed little activity towards the target
cancer cell lines. IC50 values were in the 30-70 μM range. A few of the results are relevant as
the study was performed up to 100 μM. However, most of the results obtained had very large
errors associated with the reported values. The (+)-borneol mimic showed a slightly better
activity than the other tested compounds, but due to reported errors no conclusions could be
drawn from the data. It appears that the central core of englerin A plays a larger role in the
activity than previously thought. The final proposed mimic that has not been synthesized yet
could yield better results due to the similarity to the original natural product.
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3.3 Conclusions and Future Work
(–)-Englerin A was recently discovered in 2008. Given its potent activity against renal
cancer cell lines, a total synthesis was hotly pursued by several research groups yielding several
successful routes. However, none of these syntheses produced a viable method to large scale
production which is necessary to carry out further testing of the compound.
Other large and complex natural products have been modified by inserting simplified
structures for sections of the original compound. This has been accomplished in several cases to
produce mimics of the natural products that maintain the desired biological activity while
dramatically simplifying the synthetic route.
(–)-Englerin A mimics have been proposed that maintain the ester side-chains which have
been shown to be responsible for the anti-cancer activity while simplifying the central non-polar
core. (+)-Bornyl 19, (–)-bornyl 21, and (+)-fenchyl 42 mimics of (–)-englerin A were
synthesized and tested for anti-cancer activity against two of the renal cell lines identified in the
NCI 60 panel, 786-0 and A498. Unfortunately, all mimics had IC50 values between 30-70 μM
indicating little anti-cancer activity.
Other mimics including the bridged cycloheptyl mimic will be synthesized in future work
as well as amide analogues of the proposed mimics. The bridged cycloheptyl mimic is
essentially identical to (–)-englerin A and should yield the best activity while simplifying the
synthetic route. Replacing the ester connectivity with amide bonds should also increase the
stability of the molecule to further withstand biological degradation.
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4. Experimental Details and Data
4.1 General Method and Materials
Air and moisture sensitive reactions were carried out in flame dried round bottom flasks
under a nitrogen atmosphere. All solvents were obtained from Sigma Aldrich and dried by
passing them through columns packed with activated alumina under argon. Reagents were
purchased from Sigma Aldrich and Alfa Aesar. Flash chromatography was performed using 60–
230 mesh silica gel. Thin-layer chromatography was done using Merck silica gel 60 F254 0.25
mm pre-coated TLC plates. TLC plates were visualized using UV254 or a cerium molybdate stain
with charring. All 1H and 13C NMR spectra were obtained on 500 MHz Varian spectrometers
using TMS (0.0 ppm) as the internal reference. Signal splitting is reported as s (singlet), d
(doublet), dd (doublet of doublets), t (triplet), q (quartet), and m (multiplet). Mass spectra were
obtained in the Brigham Young University mass spectrometry facility using ESI. Optical
rotations were measured on a Perkin Elmer 241 polarimeter using the sodium D line at ambient
temperature with a path length of 10 cm. Low temperature conditions were obtained by either
dry ice in acetone or with the use of an immersion cooler with a cooling probe placed in an
acetone bath.
4.2 Synthesis of Resveratrol Analogues

(E)-4-(3,5-bis(benzyloxy)styryl)phenyl acetate (1)
A 50 mL round bottom flask was charged with p-xylene (20 mL), Pd(OAc)2 (22.5 mg, 0.1
mmol), 1,3-bis-(1-adamantyl)imidazolinium tetrafluoroborate (42.6 mg, 0.1 mmol), 3,5-
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bis(benzyloxy)benzoic chloride (4.50 g, 10 mmol), 4-acetoxystyrene (2.02 g, 12.5 mmol), and Nethyl morpholine (1.58 mL, 12.5 mmol). A condenser column was installed and the flask and
column were degassed three times with Ar. The mixture was heated at 115-120 °C for 3 hours
under an Ar atmosphere. After the solution was cooled to room temperature, it was poured into a
silica gel column. Eluting solvent: 5-10% EtOAc/Hex. Flash chromatography gave 1 (3.15 g,
88%) as a white solid. Data are: H1 NMR (CDCl3, 500 MHz): δ 7.507 (d, J = 8.5 Hz, 2H), 7.407
(m, 10H), 7.094 (d, J = 8.5 Hz, 2H), 7.055 (d, J = 16 Hz, 1H), 6.977 (d, J = 16 Hz, 1H), 6.774 (d,
J = 2 Hz, 2H), 6.569 (t, J = 2 Hz, 1H), 5.084 (s, 4H), 2.318 (s, 3H); C13 NMR (CDCl3, 125

MHz): δ 169.460, 160.168, 150.145, 139.240, 136.833, 134.930, 128.823, 128.625, 128.274,
128.041, 127.568, 127.511, 121.820, 105.823, 101.628, 70.153, 21.163; HRMS found 451.1971
(M+H)+, calculated 451.19 for (C30H26O4+H)+.

(E)-4-(3,5-bis(benzyloxy)styryl)phenol (2)
A 1000 mL flame dried round bottom flask was charged with EtOH (500 mL) and KOH (5 g,
89.1 mmol). Once KOH pellets dissolved, (E)-4-(3,5-bis(benzyloxy)styryl)phenyl acetate (1 g,
2.2 mmol) was added to the flask. The mixture was stirred at room temperature for 2 hours. The
reaction was then quenched with 10% aqueous HCl. 300 mL distilled water was added to the
solution and then extracted with 50 mL EtOAc three times. Organic layers were combined and
dried over Na2SO4. Removal of solvent by rotovapor gave 2 (0.82 g, 2.0 mmol, 90%) as a white
solid. Data are: H1 NMR (CDCl3, 500 MHz): δ 7.406 (m, 12H), 7.016 (d, J = 16.5 Hz, 1H),
6.889 (d, J = 16 Hz, 1H), 6.829 (d, J = 8 Hz, 2H), 6.757 (d, J = 2 Hz, 2H), 6.546 (s, 1H), 5.080
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(s, 4H), 4.778 (s, 1H); C13 NMR (CDCl3, 125 MHz): δ 160.142, 155.298, 139.690, 136.883,
130.154, 128.747, 128.613, 129.022, 127.572, 126.569, 115.615, 105.595, 101.216, 70.134;
HRMS found 409.1858 (M+H)+, calculated 409.18 for (C28H24O3+H)+.

(E)-4-(3,5-bis(benzyloxy)styryl)phenyl pivalate (3)
A 5 mL flame dried round bottom flask was charged with pyridine (2.5 mL) and (E)-4-(3,5bis(benzyloxy)styryl)phenol (100 mg, 0.25 mmol). The solution was cooled to 0° C in an ice
bath. Pivaloyl chloride (0.15 mL, 1.22 mmol) was then added dropwise. The mixture was
allowed to warm to room temperature for 2 hours and then quenched with 10% aqueous HCl. 10
mL distilled water was added to the solution and then extracted with 5 mL dichloromethane three
times. Organic layers were combined and dried over Na2SO4. Removal of solvent by rotovapor
and then column chromatography (20% EtOAc/Hex) gave 3 (100 mg, 0.20 mmol, 83%) as a
white solid. Data are: H1 NMR (CDCl3, 500 MHz): δ 7.499 (d, J = 9 Hz, 2H), 7.404 (m, 10H),
7.057 (d, J = 8.5 Hz, 2H), 7.056 (d, J = 15.5 Hz, 1H), 6.976 (d, J = 16.5 Hz, 1H), 6.773 (d, J = 2
Hz, 2H), 6.563 (s, 1H), 5.078 (s, 4H), 1.370 (s, 9H); C13 NMR (CDCl3, 125 MHz): δ 177,032,
160.168, 150.631, 139.292, 136.849, 134.655, 128.633, 128.606, 128.375, 128.018, 127.544,
127.434, 121.738, 105.796, 101.644, 70.143, 39.098, 27.133, 27.019; HRMS found 492.4119
(M)+, calculated 492.23 for (C31H32O4)+.
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(E)-4-(3,5-dihydroxystyryl)phenyl pivalate (4)
a) To a flame dried 100 mL round bottomed flask was charged (E)-4-(3,5bis(benzyloxy)styryl)phenyl pivalate (50 mg, 0.10 mmol) and 50 mL anhydrous
dichloromethane, then dimethyl sulfide (0.2 mL, 1.75 mmol) was added followed by dropwise
addition of boron trifluoride diethyl etherate (0.15 mL, 1.22 mmol) under Ar. The septum was
sealed with parafilm. After 20 hours, the reaction was quenched with saturated NaHCO3 until pH
7 was obtained. The two layers were separated and the aqueous layer was then extracted with
dichloromethane twice. The combined organic layers were washed with brine, and then dried
with anhydrous Na2SO4. Concentration and chromatography (40% EtOAc/Hex) gave 4 (29 mg,
83%) as a white solid. Data are: H1 NMR (Methanol-d4, 500 MHz): δ 7.544 (d, J = 9 Hz, 2H),
7.048 (d, J = 16.5 Hz, 1H), 7.033 (d, J = 8.5 Hz, 2H), 6.976 (d, J = 16 Hz, 1H), 6.496 (d, J = 2
Hz, 2H), 6.205 (t, J = 2.5 Hz, 1H), 1.356 (s, 9H); C13 NMR (Methanol-d4, 125 MHz): δ 177.256,
158.352, 150.457, 139.228, 135.155, 128.846, 126.981, 121.408, 104.694, 101.853, 78.056,
38.674, 26.053; HRMS found 313.1487 (M+H)+, calculated 313.14 for (C19H20O4+H)+.
b) A flame dried 5 mL round bottomed flask was charged with (E)-5-(4-hydroxystyryl)benzene1,3-diol (51.1 mg, 0.22 mmol), 2 mL anhydrous DMF, and then purged with nitrogen. Pivalic
anhydride (0.067 mL, 0.33 mmol) and K2CO3 (100 mg, 0.72 mmol) were added in succession to
the reaction mixture and stirred for 2.5 hours. The reaction was then quenched with saturated
NaHCO3 and extracted with dichloromethane three times. The organic layers were washed with
H2O and dried with anhydrous Na2SO4. Concentration and chromatography gave 4 (27.4 mg,
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39%) as a white solid. Data are: H1 NMR (Methanol-d4, 500 MHz): δ 7.544 (d, J = 9 Hz, 2H),
7.048 (d, J = 16.5 Hz, 1H), 7.033 (d, J = 8.5 Hz, 2H), 6.976 (d, J = 16 Hz, 1H), 6.496 (d, J = 2
Hz, 2H), 6.205 (t, J = 2.5 Hz, 1H), 1.356 (s, 9H); C13 NMR (Methanol-d4, 125 MHz): δ 177.256,
158.352, 150.457, 139.228, 135.155, 128.846, 126.981, 121.408, 104.694, 101.853, 78.056,
38.674, 26.053; HRMS found 313.1487 (M+H)+, calculated 313.14 for (C19H20O4+H)+.

(E)-4-(3,5-bis(benzyloxy)styryl)phenyl benzoate (5)
A 5 mL flame dried round bottom flask was charged with pyridine (2.5 mL) and (E)-4-(3,5bis(benzyloxy)styryl)phenol (100 mg, 0.25 mmol). The solution was cooled to 0° C in an ice
bath. Benzoyl chloride (0.1 mL, 0.86 mmol) was then added dropwise. The mixture was
allowed to warm to room temperature for 2 hours and then quenched with 10% aqueous HCl.
The white precipitate was filtered out to give 5 (108.7 mg, 0.21 mmol, 87%) as a white solid.
Data are: H1 NMR (CDCl3, 500 MHz): δ 8.224 (d, J = 7 Hz, 2H), 7.571 (m, 5H), 7.410 (m,
10H), 7.229 (d, J = 8.5 Hz, 2H), 7.090 (d, J = 16.5 Hz, 1H), 7.011 (d, J = 16.5 Hz, 1H), 6.791 (d,
J = 2 Hz, 2H), 6.575 (s, 1H), 5.092 (s, 4H); C13 NMR (CDCl3, 125 MHz): δ 165.142, 160.180,

150.442, 139.267, 136.841, 134.972, 133.644, 130.200, 129.487, 128.835, 128.625, 128.594,
128.331, 128.041, 127.568, 121.969, 105.831, 101.655, 70.157; HRMS found 512.2785 (M)+,
calculated 512.20 for (C35H28O4)+.
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(E)-4-(3,5-dihydroxystyryl)phenyl benzoate (6)
a) To a flame dried 100 mL round bottomed flask was charged (E)-4-(3,5bis(benzyloxy)styryl)phenyl benzoate (50 mg, 0.10 mmol) and 50 mL anhydrous
dichloromethane, then dimethyl sulfide (0.15 mL, 1.83 mmol) was added followed by dropwise
addition of boron trifluoride diethyl etherate (0.15 mL, 1.17 mmol) under Ar. The septum was
sealed with parafilm. After 20 hours, the reaction was quenched with saturated NaHCO3 until pH
7 was obtained. The two layers were separated and the aqueous layer was then extracted with
dichloromethane twice. The combined organic layers were washed with brine, and then dried
with anhydrous Na2SO4. Concentration and chromatography (40% EtOAc/Hex) gave 6 (28 mg,
86%) as a white solid. Data are: H1 NMR (Methanol-d4, 500 MHz): 8.158 (d, J = 8 Hz, 2H),
7.665 (t, J = 7 Hz, 1H), 7.548 (m, 4H), 7.185 (d, J = 8.5 Hz, 2H), 7.059 (d, J = 16 Hz, 1H), 6.985
(d J = 16 Hz, 1H), 6.524 (d, J = 1.5 Hz, 2H), 6.236 (s, 1H); C13 NMR (Methanol-d4, 125 MHz):
δ 165.237, 158.356, 150.278, 139.266, 135.353, 133.526, 129.666, 129.307, 128.964, 128.438,
127.080, 127.023, 121.648, 104.797, 101.918; HRMS found 333.1173 (M+H)+, calculated
333.11 for (C21H16O4+H)+.
b) A flame dried 10 mL round bottomed flask was charged with (E)-5-(4hydroxystyryl)benzene-1,3-diol (49.8 mg, 0.22 mmol), 2 mL DMSO, and purged with nitrogen.
K2CO3 (33 mg, 0.24 mmol) was added and stirred for 15 minutes followed by benzoyl chloride
(0.038 mL, 0.33 mmol) and an additional 2 hours of stirring. The reaction was then quenched
with saturated NaHCO3 and extracted with EtOAc three times. The organic layers were washed
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with brine and dried with anhydrous Na2SO4. Concentration and chromatography gave 6 (23 mg,
32%) as a white solid. Data are: H1 NMR (Methanol-d4, 500 MHz): δ 8.158 (d, J = 7 Hz, 2H),
7.665 (t, J = 7 Hz, 1H), 7.543 (m, J = 9.5 Hz, 4H), 7.185 (d, J = 8.5 Hz, 2H), 7.059 (d, J = 16 Hz,
1H), 6.985 (d, J = 16 Hz, 1H), 6.523 (d, J = 2, 2H), 6.236 (s, 1H); C13 NMR (Methanol-d4, 125
MHz): δ 165.237, 158.356, 150.278, 139.266, 135.353, 133.526, 129.666, 129.307, 128.964,
128.438, 127.080, 127.023, 121.648, 104.797, 101.198; HRMS found 333.1122 (M+H)+,
calculated 333.13 for (C21H16O4+H)+.

(E)-4-(3,5-dihydroxystyryl)phenyl acetate (7)
a) To a flame dried 500 mL round bottomed flask was charged (E)-4-(3,5bis(benzyloxy)styryl)phenol acetate (716 mg, 2 mmol) and 200 mL anhydrous dichloromethane,
then dimethyl sulfide (2.95 mL, 40 mmol) was added followed by dropwise addition of boron
trifluoride diethyl etherate (3.77 mL, 30 mmol) under Ar. The septum was sealed with parafilm.
After 20 hours, the reaction was quenched with saturated NaHCO3 until pH 7 was obtained. The
two layers were separated and the aqueous layer was then extracted with dichloromethane twice.
The combined organic layers were washed with brine, and then dried with anhydrous Na2SO4.
Concentration and chromatography gave 7 (459 mg, 85%) as a white solid. Data are: H1 NMR
(Methanol-d4, 500 MHz): δ 7.540 (d, J = 8.5 Hz, 2H), 7.078 (d, J = 8.5 Hz, 2H), 7.046 (d, J =
16.6 Hz, 1H), 6.976 (d, J = 16.5 Hz, 1H), 6.493 (d, J = 2 Hz, 2H), 6.201 (t, J = 2 Hz, 1H), 2.276
(s, 3H); C13 NMR (Methanol-d4, 125 MHz): δ 169.765, 158.349, 150.163, 139.224, 135.200,
128.861, 126.973, 126.920, 121.545, 104.687, 101.849, 19.504; HRMS found 271.1039 (M+H)+,
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calculated 271.10 for (C16H14O4+H)+.
b) A flame dried 50 mL round bottomed flask was charged with (E)-5-(4-hydroxystyryl)benzene1,3-diol (50.4 mg, 0.22 mmol) and 25 mL anhydrous THF. The flask was topped with a water
cooled condenser and vented to a nitrogen atmosphere. Sodium hydride (11 mg, 0.275 mmol)
was added to the reaction flask and then heated by sand bath to 70° C. Acetic anhydride (0.03
mL, 0.32 mmol) was added to the reaction flask and allowed to stir for 2 hours. The reaction
was then cooled to room temperature and quenched with saturated NaHCO3. The reaction
mixture was extracted with dichloromethane three times. The organic layers were washed with
brine, and then dried with anhydrous Na2SO4. Concentration and chromatography gave 7 (23.9
mg, 40%) as a white solid. Data are: H1 NMR (Methanol-d4, 500 MHz): δ 7.540 (d, J = 8.5 Hz,
2H), 7.078 (d, J = 8.5 Hz, 2H), 7.046 (d, J = 16.6 Hz, 1H), 6.976 (d, J = 16.5 Hz, 1H), 6.493 (d,
J = 2 Hz, 2H), 6.201 (t, J = 2 Hz, 1H), 2.276 (s, 3H); C13 NMR (Methanol-d4, 125 MHz): δ

169.765, 158.349, 150.163, 139.224, 135.200, 128.861, 126.973, 126.920, 121.545, 104.687,
101.849, 19.504; HRMS found 271.1039 (M+H)+, calculated 271.10 for (C16H14O4+H)+.
c) A flame dried 50 mL round bottomed flask was charged with (E)-5-(4hydroxystyryl)benzene-1,3-diol (50 mg, 0.22 mmol) and 25 mL HPLC grade acetone dried with
molecular sieves. The flask was cooled to 0° C and purged with nitrogen. Acetic anhydride
(0.025 mL, 0.26 mmol) and K2CO3 (66 mg, 0.48 mmol) were added in succession to the reaction
mixture and stirred for 30 minutes. The reaction was then quenched with saturated NaHCO3 and
extracted with dichloromethane three times. The organic layers were washed with brine and
dried with anhydrous Na2SO4. Concentration and chromatography gave 7 (14.2 mg, 24%) as a
white solid. Data are: H1 NMR (Methanol-d4, 500 MHz): δ 7.540 (d, J = 8.5 Hz, 2H), 7.078 (d,
J = 8.5 Hz, 2H), 7.046 (d, J = 16.6 Hz, 1H), 6.976 (d, J = 16.5 Hz, 1H), 6.493 (d, J = 2 Hz, 2H),
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6.201 (t, J = 2 Hz, 1H), 2.276 (s, 3H); C13 NMR (Methanol-d4, 125 MHz): δ 169.765, 158.349,
150.163, 139.224, 135.200, 128.861, 126.973, 126.920, 121.545, 104.687, 101.849, 19.504;
HRMS found 271.1039 (M+H)+, calculated 271.10 for (C16H14O4+H)+.

(E)-4-(3,5-dihydroxystyryl)phenyl butyrate (8)
A flame dried 10 mL round bottomed flask was charged with (E)-5-(4-hydroxystyryl)benzene1,3-diol (50.1 mg, 0.22 mmol), NaH (9.8 mg, 0.25 mmol), 2 mL THF, and purged with nitrogen.
The flask was topped with a water condenser and heated to 80° C. Butyric anhydride (0.05 mL,
0.31 mmol) was added to the reaction mixture and stirred for 2 hours. The reaction was then
quenched with saturated NaHCO3 and extracted with DCM three times. The organic layers were
washed with H2O and dried with anhydrous Na2SO4. Concentration and chromatography gave 8
(18 mg, 27%) as a white solid. Data are: H1 NMR (Methanol-d4, 500 MHz): δ 7.529 (d, J = 8.5
Hz, 2H), 7.053 (d, J = 8.5 Hz, 2H), 7.036 (d, J = 16.5 Hz, 1H), 6.965 (d, J = 16.5 Hz, 1H), 6.487
(d, J = 1.5 Hz, 2H), 6.196 (s, 1H), 2.552 (t, J = 7 Hz, 2H), 1.753 (sextet, J = 7 Hz, 2H), 1.038 (t,
J = 7 Hz, 3H); C13 NMR (Methanol-d4, 125 MHz): δ 172.364, 158.342, 150.176, 139.243,

135.171, 128.860, 127.008, 126.936, 121.513, 104.725, 101.887, 35.489, 17.984, 12.447; HRMS
found 299.1255 (M+H)+, calculated 299.13 for (C18H18O4+H)+.
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(E)-4-(3,5-dihydroxystyryl)phenyl isobutyrate (9)
A flame dried 10 mL round bottomed flask was charged with (E)-5-(4-hydroxystyryl)benzene1,3-diol (50 mg, 0.22 mmol) and 5 mL THF. K2CO3 (45.4 mg, 0.33 mmol) was added to the
reaction flask topped with a water condenser and heated to 60 C. The reaction was stirred for 30
minutes and then cooled to room temperature. The flask was purged with nitrogen and cooled to
-78 C. Isobutyric anhydride (0.055 mL, 0.33 mmol) was added stirred for 2 hours. The reaction
was then quenched with saturated NaHCO3 and extracted with DCM three times. The organic
layers were washed with H2O and dried with anhydrous Na2SO4. Concentration and
chromatography gave 9 (19 mg, 29%) as a white solid. Data are: H1 NMR (Methanol-d4, 500
MHz): δ 7.520 (d, J = 8.5 Hz, 2H), 7.036 (d, J = 8.5 Hz, 2H), 7.031 (d, J = 16 Hz, 1H), 6.960 (d,
J = 16 Hz, 1H), 6.492 (d, J = 2 Hz, 2H), 6.207 (t, J = 1.5 Hz, 1H), 2.801 (septet, J = 7 Hz, 1H),

1.284 (d, J = 7 Hz, 6H); C13 NMR (Methanol-d4, 125 MHz): δ 175.851, 158.338, 150.274,
139.262, 135.167, 128.860, 127.031, 126.959, 121.419, 104.759, 101.906, 33.869, 17.821;
HRMS found 299.1244 (M+H)+, calculated 299.13 for (C18H18O4+H)+.
Selective esterification of resveratrol in DCM
A flame dried 50 mL round bottomed flask was charged with (E)-5-(4-hydroxystyryl)benzene1,3-diol (52.3 mg, 0.22 mmol) and 30 mL DCM. Pyridine (0.05 mL, 0.62 mmol) was added and
stirred for 5 minutes followed by acetyl chloride (0.05 mL, 0.69 mmol) and an additional 60
minutes of stirring. The reaction was then quenched with saturated NaHCO3 and extracted with
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DCM three times. The organic layers were washed with brine and dried with anhydrous Na2SO4.
Concentration gave all tri-AR by NMR. No yield calculated.
Selective esterification of resveratrol in H2O
A flame dried 50 mL round bottomed flask was charged with (E)-5-(4-hydroxystyryl)benzene1,3-diol (51.5 mg, 0.22 mmol), 25 mL H2O, and NaOH (26.5 mg, 0.68 mmol). The solution was
then cooled to 0° C followed by addition of acetic anhydride (0.02 mL, 0.22 mmol) and 2 hours
of stirring. The reaction was then quenched with saturated NaHCO3 and extracted with Et2O
three times. The organic layers were washed with brine and dried with anhydrous Na2SO4.
Concentration gave 3-AR to 4’-AR in a ratio of 1.2:1.0 by NMR. No yield calculated.
Selective esterification of resveratrol in EtOH
A flame dried 50 mL round bottomed flask was charged with (E)-5-(4-hydroxystyryl)benzene1,3-diol (52.9 mg, 0.22 mmol), 25 mL EtOH, and K2CO3 (32.9 mg, 0.24 mmol). The solution
was then cooled to 0° C followed by addition of acetic anhydride (0.02 mL, 0.22 mmol) and 2
hours of stirring. The reaction was then quenched with saturated NaHCO3 and extracted with
Et2O three times. The organic layers were washed with brine and dried with anhydrous Na2SO4.
Concentration gave 3-AR to 4’-AR in a ratio of 1.3:1.0 by NMR. No yield calculated.
Selective esterification of resveratrol in DMSO
A flame dried 10 mL round bottomed flask was charged with (E)-5-(4- hydroxystyryl)benzene-1,3diol (25 mg, 0.11 mmol) and 5 mL anhydrous DMSO. Triethylamine (15.3 μL, 0.11 mmol) was
added to the reaction flask and then stirred for 20 min. Acetic anhydride (10.3 μL, 0.11 mmol) was
added to the reaction flask and allowed to stir for 1 hr. The reaction was then quenched with distilled
H2O. The reaction mixture was extracted with 10 mL diethyl ether three times. The organic layers
were dried with anhydrous Na2SO4. Concentration and chromatography gave 7 (14 mg, 47%) as a
white solid. Data are: 1H NMR (Methanol-d4, 500 MHz): δ 7.540 (d, J = 8.5 Hz, 2H), 7.078 (d, J =
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8.5 Hz, 2H), 7.046 (d, J = 16.6 Hz, 1H), 6.976 (d, J = 16.5 Hz, 1H), 6.493 (d, J = 2 Hz, 2H), 6.201 (t,
J = 2 Hz, 1H), 2.276 (s, 3H); 13C NMR (Methanol-d4, 125 MHz): δ 169.765, 158.349, 150.163,
139.224, 135.200, 128.861, 126.973, 126.920, 121.545, 104.687, 101.849, 19.504; HRMS found
271.1039 (M+H)+, calculated 271.10 for (C16H14O4+H)+.

General procedure using metal Lewis acid catalysts with resveratrol
A flame dried 50 mL round bottomed flask was charged with (E)-5-(4-hydroxystyryl)benzene1,3-diol (50 mg, 0.22 mmol), 25 mL of THF or CH3CN, and Ac2O (0.03 mL, 0.33 mmol). The
metal catalyst (0.02 mmol) was then added to the solution and stirred at room temperature for
12-18 hours. The reaction was then quenched with saturated NaHCO3 and extracted with DCM
three times. The organic layers were washed with brine and dried with anhydrous Na2SO4.
Concentration gave a mixture of esterified products analyzed by NMR. No yields calculated.
Selective esterification of resveratrol using n-BuLi
A flame dried 50 mL round bottomed flask was charged with (E)-5-(4-hydroxystyryl)benzene1,3-diol (50.4 mg, 0.22 mmol), 25 mL THF, and then purged with nitrogen. The solution was
then cooled to -78° C followed by addition of n-butyl lithium (0.15 mL, 0.24 mmol) and 30
minutes of stirring. Acetic anhydride (0.03 mL, 0.33 mmol) was then added and stirred for an
additional 3 hours. The reaction was then quenched with saturated NaHCO3 and extracted with
DCM three times. The organic layers were washed with brine and dried with anhydrous Na2SO4.
Concentration gave 3-AR/4’-AR/Resveratrol in a ratio of 1:4.4:3.6 by NMR. No yield
calculated.
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4.3 Oxidation Optimization

(1S,2R,4S,5S)-5-hydroxy-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl acetate (11)
a) (–)-Bornyl acetate (50 mg, 0.25), Na2·EDTA (0.1 mL, 0.4 mM, 0.04 μmol) and 3 mL
CH3CN were added to a 10 mL flame dried round bottom flask. The solution was then cooled to
0° C in an ice bath. TFA (0.23 mL, 2.6 mmol) was then added by cooled syringe to the reaction
flask. NaHCO3 (166 mg, 2.0 mmol) and Oxone (391 mg, 1.3 mmol) were mixed and then added
in small portions to the reaction over 1 hour. The reaction was monitored for 4 hours, but no
desired product formed.
b) (–)-Bornyl acetate (100 mg, 0.51 mmol), Fe(PDP) (2.4 mg, 3 μmol), 2 mL CH3CN, and
AcOH (14.5 μL, 0.26 mmol) were added to a 25 mL flame dried round bottom flask. The
solution was stirred vigorously at room temperature. H2O2 (34.7 μL, 1.2 μmol) was then added
to 4.5 mL CH3CN. This solution was then added dropwise to the reaction flask over 60 seconds.
A second solution of H2O2 was prepared and added to the reaction flask after 10 minutes.
Concentration and then extraction with Et2O was followed by filtering the organic layers through
filter paper to remove the iron catalyst. Concentration and flash chromatography in 20%
EtOAc/Hex yielded 11 (18 mg, 17%) as a clear liquid. Data are: 1H NMR (CDCl3, 500 MHz): δ
5.071 (d, J = 9.2 Hz, 1H), 2.634 (m, 1H), 2.568 (d, J = 18.5 Hz, 1H), 2.194 (d, J = 5.5 Hz, 1H), 2.091
(s, 3H), 2.039 (s, 1H), 1.327 (dd, J = 15, 3 Hz, 1H), 1.020 (s, 3H), 1.009 (s, 3H), 0.950 (s, 3H); 13C
NMR (CDCl3, 125 MHz): δ 216.09, 177.06, 110.31, 76.77, 59.75, 49.43, 41.98, 31.88, 20.07, 17.57,
12.75; HRMS found 211.1265 (M+H)+, calculated 211.13 for (C12H18O3+H)+.
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c) (–)-Bornyl acetate (200 mg, 1.0 mmol) and 12 mL benzene was added to a 25 mL flame dried
round bottom flask. Celite (1.2 g, 20 mmol), pyridinium dichromate (1.5 g, 4.0 mmol), and tbutyl hydroperoxide (0.727 mL, 70% soln., 4 mmol) were added to the solution and stirred at 10°
C for 15 minutes. The reaction was then allowed to warm to room temperature and stirred for
another 4 hours. The reaction was then extracted with Et2O and filtered through celite. The
organic layers were concentrated and purified by flash chromatography in 10% EtOAc/Hex.
Only unreacted starting material was recovered.
d) (–)-Bornyl acetate (200 mg, 1 mmol) and 7.5 mL CHCl3 were added to a 25 mL flame dried
round bottom flask. NaIO4 (638 mg, 3 mmol), 7.5 mL H2O, and I2 (6.3 mg, 0.05 mmol) were
combined in a separate flask then added to the main reaction flask. The reaction was stirred for 4
hours and then extracted with CHCl3. The organic layers were combined, washed with 1M HCl
(aq.), and then dried with Na2SO4. TLC in 10% EtOAC/Hex showed little to no conversion of
starting material to desired product.
e) (–)-Bornyl acetate (200 mg, 1 mmol), TBHP (0.91 mL, 5 mmol), and 12 mL CH3CN/H2O
(3:1 v/v) were added to a 25 mL flame dried round bottom flask. NaClO2 (136 mg, 1.2 mmol)
was then added slowly over 5 minutes. The reaction was then heated to 50° C for 18 hours. The
reaction mixture was then cooled and poured in to a 10% Na2SO3 solution and extracted with
Et2O. The organic layers were combined and dried with Na2SO4. TLC showed no conversion of
starting material to desired product.
f) (–)-Bornyl acetate (200 mg, 1 mmol), 20% Pd(OH)2/C (26.5 mg, 0.05 mmol), Na2HPO4 (14.1
mg, 0.1 mmol), and 3 mL DCM were added to a 25 mL flame dried round bottom flask. The
flask was purged with O2. TBHP (62.5 μL, 0.63 mmol) was added in four portions every two
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hours while the reaction was stirred vigorously. After 24 hours the reaction was checked by
TLC in 10% EtOAc/Hex which showed no conversion of starting material to desired product.
g) (–)-Bornyl acetate (200 mg, 1 mmol), Rh2(cap)4 (3.7 mg, 5 μmol), and 2 mL DCM were
added to a 10 mL flame dried round bottom flask. TBHP (0.55 mL, 4 mmol) was added to the
reaction which was then stirred for 16 hours. A second portion of Rh2(cap)4 and TBHP were
added and the reaction was allowed to continue for 24 hours. After 24 hours the reaction was
checked by TLC in 10% EtOAc/Hex which showed no conversion of starting material to desired
product.

(1R,2R,4S)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl picolinate (12)
(+)-Fenchol (105 mg, 0.68 mmol), 2-picolinic acid (160 mg, 1.3 mmol), EDCI (111 mg, 0.72
mmol), DMAP (8 mg, 0.07 mmol), and 10 mL DCM were added to a 25 mL flame dried round
bottom flask. The reaction was stirred for 2 hours and then quenched with H2O and extracted
with DCM. Organic extracts were combined and dried with Na2SO4. Concentration and flash
chromatography in 15% EtOAc/Hex yielded 12 (51 mg, 29%) as a clear liquid. Data are: 1H
NMR (CDCl3, 500 MHz): δ 8.777 (d, J = 4.5 Hz, 1H), 8.070 (d, J = 7.5, 1H), 7.816 (t, J = 7.5 Hz,
1H), 7.443 (t, J = 6 Hz, 1H), 4.700 (d, J = 2.5 Hz, 1H), 1.926 (m, 1H), 1.768 (m, 2H), 1.660 (d, J =
10 Hz, 1H), 1.503 (m, 1H), 1.247 (d, J = 10.5 Hz, 1H), 1.209 (d, J = 22.5 Hz, 1H) , 1.182 (s, 3H) ,
1.106 (s, 3H) , 0.844 (s, 3H).
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(1S,2R,4S)-1,3,3-trimethyl-5-oxobicyclo[2.2.1]heptan-2-yl picolinate (12a)
12 (51 mg, 0.20 mmol) was added to a flame dried round bottom flask with 5 mL AcOH. The
flask was topped with a water condenser and heated to reflux (115° C) with a sand bath. CrO3
(80 mg, 0.8 mmol) was dissolved in 3 mL AcOH. The chromium solution was added dropwise
over 1 hour. The reaction was then allowed to stir at reflux for 1.5 hours. A second CrO3
solution was prepared (80 mg, 0.8 mmol) and added to the reaction over 1 hour. After refluxing
for another 1.5 hours, the reaction was quenched with H2O and extracted with Et2O. The Et2O
extracts were combined and neutralized with NaHCO3. The organic layer was then dried with
Na2SO4. Concentration and flash chromatography in 40% EtOAc/Hex yielded no desired
product.

(1S,2R,4S,5R)-5-(benzyloxy)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl picolinate (13)
12 (32 mg, 0.12 mmol), Pd(OAc)2 (3 mg, 13 μmol), PhI(OAc)2 (100 mg, 0.31 mmol), benzyl
alcohol (0.5 mL, 4.8 mmol), and 2 mL p-xylene were added to a 10 mL flame dried round
bottom flask. The reaction was stirred and atmosphere purged with N2. The flask was topped
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with a water condenser and headed to 110° C. After 2 hours no reaction products were observed.
The reaction continued to be stirred for 72 hours at which point the starting material was
consumed. However, no desired product was observed by NMR after purification by flash
chromatography in 25% EtOAc/Hex.

(1R,2R,4S)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl 1H-pyrazole-3-carboxylate (18)
(+)-Fenchol (100 mg, 0.65 mmol), 1H-pyrazole-3-carboxylic acid (145 mg, 1.3 mmol), EDCI
(111 mg, 0.72 mmol), DMAP (8 mg, 0.07 mmol), and 10 mL DCM were added to a 25 mL
flame dried round bottom flask. The reaction was stirred for 2 hours and then quenched with
H2O and extracted with DCM. Organic extracts were combined and dried with Na2SO4.
Concentration and flash chromatography in 20% EtOAc/Hex yielded 18 (82 mg, 51%) as a clear
liquid. Data are: 1H NMR (CDCl3, 500 MHz): δ 7.837 (s, 1H), 6.842 (s, 1H), 4.661 (s, 1H), 1.911
(m, 1H), 1.784 (m, 2H), 1.688 (d, J = 10 Hz, 1H), 1.520 (m, 1H), 1.279 (d, J = 9.5 Hz, 1H), 1.204 (s,
4H), 1.130 (s, 3H), 0.864 (s, 3H).
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(1S,2R,4S)-1,3,3-trimethyl-5-oxobicyclo[2.2.1]heptan-2-yl 1H-pyrazole-3-carboxylate (18a)
18 (46 mg, 0.19 mmol) was added to a flame dried round bottom flask with 5 mL AcOH. The
flask was topped with a water condenser and heated to reflux (115° C) with a sand bath. CrO3
(75 mg, 0.75 mmol) was dissolved in 3 mL AcOH. The chromium solution was added dropwise
over 1 hour. The reaction was then allowed to stir at reflux for 1.5 hours. A second CrO3
solution was prepared (75 mg, 0.75 mmol) and added to the reaction over 1 hour. After refluxing
for another 1.5 hours, the reaction was quenched with H2O and extracted with Et2O. The Et2O
extracts were combined and neutralized with NaHCO3. The organic layer was then dried with
Na2SO4. Concentration yielded no desired product after flash chromatography in 20%
EtOAc/Hex.
4.4 Synthesis of Englerin A Mimics
4.4.1 (–)-Bornyl Mimic

(1S,2R,4S)-1,7,7-trimethyl-5-oxobicyclo[2.2.1]heptan-2-yl acetate (11)
(1S,2R,4S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl acetate 10 (1 g, 5.10 mmol) was added to a
flame dried round bottom flask with 5 mL AcOH. The flask was topped with a water condenser
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and heated to reflux (115° C) with a sand bath. CrO3 (1.8 g, 18 mmol) was dissolved in 3 mL
AcOH. The chromium solution was added dropwise over 1 hour. The reaction was then allowed
to stir at reflux for 1.5 hours. A second CrO3 solution was prepared (1.8 g, 18 mmol) and added
to the reaction over 1 hour. After refluxing for another 1.5 hours, the reaction was quenched
with H2O and extracted with Et2O. The Et2O extracts were combined and neutralized with
NaHCO3. The organic layer was then dried with Na2SO4. Concentration and flash
chromatography in 10% EtOAc/Hex yielded 11 (747 mg, 68%) as a clear liquid. Data are: 1H
NMR (CDCl3, 500 MHz): δ 5.071 (d, J = 9.2 Hz, 1H), 2.634 (m, 1H), 2.568 (d, J = 18.5 Hz, 1H),
2.194 (d, J = 5.5 Hz, 1H), 2.091 (s, 3H), 2.039 (s, 1H), 1.327 (dd, J = 15, 3 Hz, 1H), 1.020 (s, 3H),
1.009 (s, 3H), 0.950 (s, 3H); 13C NMR (CDCl3, 125 MHz): δ 216.09, 177.06, 76.77, 59.74, 49.41,
47.07, 41.96, 31.87, 21.07, 20.03, 17.54, 12.73; HRMS found 211.1265 (M+H)+, calculated 211.13
for (C12H18O3+H)+.

(1S,2R,4S,5S)-5-hydroxy-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl acetate (11a)
11 (747 mg, 3.5 mmol) was added to a flame dried 25 mL round bottom flask with 10 mL MeOH
and CeCl3·7H2O (2.6 g, 10.5 mmol). The reaction was stirred at room temperature for 30
minutes and then cooled to –78° C in an acetone bath with dry ice. NaBH4 (270 mg, 7.1 mmol)
was added in small portions over 2 hours. The reaction was allowed to warm to room
temperature and then H2O was added slowly until bubbles ceased to form. The reaction mixture
was extracted with Et2O. The organic layers were combined and dried with Na2SO4.
Concentration and flash chromatography in 20% EtOAc/Hex yielded 11a (623 mg, 83%) as a
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clear liquid. Data are: 1H NMR (CDCl3, 500 MHz): δ 4.681 (d, J = 10 Hz, 1H), 3.755 (d, J = 8.5
Hz, 1H), 2.802 (s, 1H), 2.252 (m, 2H), 1.937 (s, 3H), 1.650 (d, J = 6 Hz, 1H), 1.361 (d, J = 13 Hz,
1H), 1.011 (s, 3H), 0.785 (s, 3H), 0.767 (s, 3H), 0.697 (d, J = 13.5 Hz, 1H); 13C NMR (CDCl3, 125
MHz): δ 171.28, 78.32, 74.78, 52.37, 49.54, 47.28, 39.25, 34.13, 21.07, 20.59, 19.74, 12.79; HRMS
found 230.1732 (M+NH4)+, calculated 230.18 for (C12H20O3+NH4)+.

(1S,2R,4S,5S)-5-((tert-butyldimethylsilyl)oxy)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl
acetate (23)
11a (508 mg, 2.4 mmol) was added to a 10 mL flame dried round bottom flask with 5 mL DMF
and imidazole (489 mg, 7.2 mmol). The reaction was stirred and cooled to 0° C in an ice bath.
TBSCl (722 mg, 4.8 mmol) was then added in one portion. The reaction was then allowed to
warm to room temperature and was stirred for an additional 4 hours. H2O was then added to
quench the reaction. The reaction mixture was then extracted with Et2O. The organic layers
were combined and dried with Na2SO4. Concentration and flash chromatography yielded 23
(775 mg , 99%) as a clear liquid. Data are: 1H NMR (CDCl3, 500 MHz): δ 4.773 (d, J = 10 Hz,
1H), 3.706 (d, J = 8.5 Hz, 1H), 2.289 (m, 2H), 2.012 (s, 3H), 1.643 (d, J = 5 Hz, 1H), 1.405 (d, J =
13.5 Hz, 1H), 1.065 (s, 3H), 0.879 (s, 9H), 0.841 (s, 3H), 0.818 (s, 3H), 0.740 (d, J = 14 Hz, 1H),
–0.001 (s, 3H) , –0.006 (s, 3H); 13C NMR (CDCl3, 125 MHz): δ 171.39, 78.56, 75.18, 52.51, 49.34,
47.47, 40.56, 34.00, 25.71, 25.62, 21.13, 20.69, 19.76, 12.82, –3.67, –4.83; HRMS found 327.2381
(M+H)+, calculated 327.24 for (C18H34O3Si+H)+.
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(1S,2R,4S,5S)-5-((tert-butyldimethylsilyl)oxy)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-ol
(23a)
23 (800 mg, 2.5 mmol) was added to a 25 mL flame dried round bottom flask with 5 mL DCM.
The reaction flask was capped with a rubber septum and purged with N2. After cooling to –40°
C in an acetone bath, DIBAL (3.6 mL, 5.4 mmol, 1.5M in toluene) was added dropwise. The
reaction was stirred at –40° C for 1 hour. 5 mL MeOH was then added slowly followed by 5 mL
Rochelle’s salt’s (saturated aqueous solution). The solution was then stirred vigorously for 2
hours while warming to room temperature. The reaction was then extracted with DCM and
washed with brine. The organic layers were combined and dried with Na2SO4. Concentration
followed by purification using a silica gel plug yielded 23a (691 mg, 99%) as a clear liquid.
Data are: 1H NMR (CDCl3, 500 MHz): δ 3.883 (d, J = 9.5 Hz, 1H), 3.744 (d, J = 7.5 Hz, 1H), 2.245
(m, 2H), 1.621 (d, J = 5 Hz, 1H), 1.355 (d, J = 14.5 Hz, 1H), 1.073 (s, 3H), 0.903 (s, 3H), 0.854 (s,
9H), 0.805 (s, 3H), 0.741 (d, J = 14 Hz, 1H), 0.084 (s, 3H) , 0.006 (s, 3H); 13C NMR (CDCl3, 125
MHz): δ 75.98, 75.35, 52.92, 47.82, 39.49, 36.07, 25.77, 25.62, 22.61, 19.65, 17.82, 12.72, –3.62,
–4.81; HRMS found 285.2311 (M+H)+, calculated 285.22 for (C16H32O2Si+H)+.
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(1S,2R,4S,5S)-5-((tert-butyldimethylsilyl)oxy)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl
cinnamate (22)
23a (700 mg, 2.5 mmol) was added to a flame dried 50 mL round bottom flask containing 10 mL
DCM. Pyridine (0.5 mL, 24.3 mmol) was added and then the flask was purged with N2 gas. The
reaction was cooled to 0° C in an ice bath. Cinnamoyl chloride (1.025 g, 6.2 mmol) was added
in small portions over 10 minutes. After stirring for 2 hours, the reaction was quenched with
10% HCl (aq.) and extracted with DCM. Organic layers were combined and dried with Na2SO4.
Concentration and flash chromatography in 10% EtOAc/Hex yielded 22 (1.26 g, 99%) as a clear
liquid. Data are: 1H NMR (CDCl3, 500 MHz): δ 7.678 (d, J = 16 Hz, 1H), 7.556 (m, 2H), 7.395 (m,
3H), 6.475 (d, J = 16.5 Hz, 1H), 4.928 (d, J = 10.5 Hz, 1H), 3.798 (d, J = 8 Hz, 1H), 2.420 (m, 2H),
1.722 (d, J = 4.5 Hz, 1H), 1.500 (d, J = 13.5 Hz, 1H), 1.134 (s, 3H), 0.924 (s, 3H), 0.919 (s, 3H),
0.895 (s, 9H), 0.864 (d, J = 4 Hz, 1H), 0.058 (s, 3H), 0.048 (s, 3H); 13C NMR (CDCl3, 125 MHz): δ
167.19, 144.39, 134.50, 130.20, 128.86, 128.07, 118.61, 78.64, 75.28, 52.64, 49.67, 47.63, 40.79,
34.22, 25.80, 20.79, 19.92, 17.87, 12.99, –4.71, –4.82; HRMS found 415.2676 (M+H)+, calculated
415.27 for (C25H38O3Si+H)+.
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(1S,2R,4S,5S)-5-hydroxy-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl cinnamate (22a)
22 (450 mg, 1.1 mmol) and 10 mL THF was added to a 25 mL flame dried round bottom flask.
The reaction was cooled to 0° C in an ice bath. TBAF (5.4 mL, 1M in THF, 20.7 mmol) was
added by syringe to the reaction which was then allowed to warm to room temperature. Stirring
continued for 2 days. The reaction was then quenched with H2O and extracted with DCM.
Organic layers were combined and dried with Na2SO4. Concentration and flash chromatography
in 10% EtOAc/Hex yielded 22a (300 mg, 92%) as a clear liquid. Data are: 1H NMR (CDCl3, 500
MHz): δ 7.649 (d, J = 16 Hz, 1H), 7.528 (m, 2H), 7.376 (m, 3H), 6.436 (d, J = 16 Hz, 1H), 3.927 (d,
J = 8 Hz, 1H), 3.537 (d, J = 5.5 Hz, 1H), 2.443 (m, 2H), 1.783 (d, J = 5 Hz, 1H), 1.514 (d, J = 14 Hz,
1H), 0.928 (s, 3H), 0.921 (s, 3H), 0.866 (s, 3H), 0.788 (d, J = 14 Hz, 1H); 13C NMR (CDCl3, 125
MHz): δ 171.10, 144.48, 134.45, 130.22, 128.84, 128.03, 118.46, 78.34, 75.26, 52.73, 49.96, 47.47,
39.58, 34.32, 20.97, 17.95, 12.91; HRMS found 301.1775 (M+H)+, calculated 301.18 for
(C19H24O3+H)+.
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(1S,2R,4S,5S)-5-(2-((tert-butyldimethylsilyl)oxy)acetoxy)-1,7,7trimethylbicyclo[2.2.1]heptan-2-yl cinnamate (22b)
22a (300 mg, 1 mmol) and 10 mL DCM were added to a 50 mL flame dried round bottom flask.
Pyridine (0.5 mL, 6.2 mmol) was added to the reaction flask and then purged with N2. 2-((tertbutyldimethylsilyl)oxy)acetyl chloride 24 (629 mg, 3.0 mmol) was added in one portion to the
reaction and stirred for 4 hours. The reaction was then quenched with H2O and extracted with
DCM. The organic layers were combined and dried with Na2SO4. Concentration and flash
chromatography in 10% EtOAc/ Hex yielded 22b (63 mg, 13%) as a clear liquid. Data are: 1H
NMR (CDCl3, 500 MHz): δ 7.653 (d, J = 16.5 Hz, 1H), 7.519 (m, 2H), 7.365 (m, 3H), 6.434 (d, J =
16 Hz, 1H), 4.961 (t, J = 8 Hz, 1H), 4.863 (d, J = 8 Hz, 1H), 4.185 (s, 2H), 2.544 (m, 2H), 2.228 (s,
1H), 2.048 (d, J = 5 Hz, 1H), 1.672 (d, J = 14.5 Hz, 1H), 1.069 (s, 3H), 0.956 (s, 3H), 0.928 (s, 3H),
0.904 (s, 9H), 0.089 (s, 3H), 0.068 (s, 3H); 13C NMR (CDCl3, 125 MHz): δ 171.28, 167.02, 157.51,
144.90, 134.36, 130.33, 128.86, 128.10, 118.23, 79.74, 77.87, 61.96, 49.95, 47.74, 37.16, 34.00,
25.73, 20.44, 19.53, 18.34, 12.75, –3.59, –5.46; HRMS found 473.2874 (M+H)+, calculated 473.27
for (C27H40O5Si+H)+.
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(1S,2R,4S,5S)-5-(2-hydroxyacetoxy)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl cinnamate
(21)
22b (63 mg, 0.13 mmol) and 10 mL THF were added to a 25 mL flame dried round bottom flask.
The reaction was cooled to 0° C in an ice bath. TBAF (1.5 mL, 1M in THF, 1.5 mmol) was
added by syringe to the reaction and then stirred for 2 days. The reaction was quenched with
H2O and extracted with DCM. Organic layers were combined and dried with Na2SO4.
Concentration and flash chromatography in 20% EtOAc/Hex yielded 21 (20 mg, 43%) as a clear
liquid. Data are: 1H NMR (CDCl3, 500 MHz): δ 7.660 (d, J = 16 Hz, 1H), 7.538 (m, 2H), 7.388 (m,
3H), 6.443 (d, J = 16 Hz, 1H), 4.958 (d, J = 9.5 Hz, 1H), 4.838 (d, J = 8 Hz, 1H), 4.118 (s, 2H),
2.565 (m, 3H), 1.989 (d, J = 4.5 Hz, 1H), 1.613 (d, J = 14 Hz, 1H), 1.059 (d, J = 15 Hz, 1H), 1.020
(s, 3H), 0.949 (s, 3H), 0.935 (s, 3H); 13C NMR (CDCl3, 125 MHz): δ 173.06, 167.16, 144.68, 134.58,
130.25, 128.87, 128.06, 118.45, 78.37, 75.28, 60.30, 49.98, 47.49, 37.44, 34.33, 20.72, 19.87, 14.17,
12.94; HRMS found 359.1874 (M+H)+, calculated 359.19 for (C21H26O5+H)+.
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4.4.2 (+)-Bornyl Mimic

(1R,2S,4R)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl acetate (14)
(+)-Borneol 25 (639 mg, 4.1 mmol) and 10 mL DCM were added to a 25 mL flame dried round
bottom flask. Pyridine (1.7 mL, 21.1 mmol) was added and the reaction flask was purged with
N2. After cooling the reaction to 0° C, acetyl chloride (1.48 mL, 20.7 mmol) was added
dropwise to the reaction. The reaction was stirred for 1 hour and then quenched with H2O and
extracted with DCM. The combined organic layers were then dried with Na2SO4. Concentration
and flash chromatography in 5% EtOAc/Hex yielded 14 (807 mg, 99%) as a clear liquid. Data
are: 1H NMR (CDCl3, 500 MHz): δ 4.719 (d, J = 10 Hz, 1H), 2.183 (m, 1H), 1.872 (s, 3H), 1.794
(m, 1H), 1.584 (m, 1H), 1.503 (s, 1H), 1.104 (m, 2H), 0.802 (d, J = 13.5 Hz, 1H), 0.744 (s, 3H),
0.712 (s, 3H), 0.667 (s, 3H); 13C NMR (CDCl3, 125 MHz): δ 170.67, 79.44, 48.46, 47.55, 44.74,
36.58, 27.85, 26.89, 19.49, 18.60, 13.24; HRMS found 214.1821 (M+NH4)+, calculated 214.16 for
(C12H20O2+NH4)+; [α]D20 +71.8 (c 20.3, CH2Cl2).

(1R,2S,4R)-1,7,7-trimethyl-5-oxobicyclo[2.2.1]heptan-2-yl acetate (15)
14 (742 mg, 3.8 mmol) was added to a flame dried round bottom flask with 5 mL AcOH. The
flask was topped with a water condenser and heated to reflux (115° C) with a sand bath. CrO3
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(1.5 g, 15 mmol) was dissolved in 3 mL AcOH. The chromium solution was added dropwise
over 1 hour. The reaction was then allowed to stir at reflux for 1.5 hours. A second CrO3
solution was prepared (1.5 g, 15 mmol) and added to the reaction over 1 hour. After refluxing
for another 1.5 hours, the reaction was quenched with H2O and extracted with Et2O. The Et2O
extracts were combined and neutralized with NaHCO3. The organic layer was then dried with
Na2SO4. Concentration and flash chromatography in 10% EtOAc/Hex yielded 15 (546 mg,
69%) as clear spindle crystals. Data are: 1H NMR (CDCl3, 500 MHz): δ 4.922 (d, J = 8.5 Hz, 1H),
2.480 (m, 1H), 2.382 (d, J = 19 Hz, 1H), 2.021 (d, J = 5 Hz, 1H), 1.905 (s, 3H), 1.846 (d, J = 16.5
Hz, 1H), 1.148 (dd, J = 15.5, 3.5 Hz, 1H), 0.876 (s, 3H), 0.861 (s, 3H), 0.797 (s, 3H); 13C NMR
(CDCl3, 125 MHz): δ 215.33, 170.65, 77.36, 59.58, 49.27, 46.90, 41.79, 31.70, 20.84, 19.91, 17.41,
12.60; HRMS found 211.1387 (M+H)+, calculated 211.13 for (C12H18O3+H)+; [α]D20 +99.3 (c 19.9,

CH2Cl2).

(1R,2S,4R,5R)-5-hydroxy-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl acetate (26)
15 (350 mg, 1.7 mmol) was added to a flame dried 25 mL round bottom flask with 10 mL MeOH
and CeCl3·7H2O (1.23 g, 3.3 mmol). The reaction was stirred at room temperature for 30
minutes and then cooled to –78° C in an acetone bath with dry ice. NaBH4 (126 mg, 3.3 mmol)
was added in small portions over 2 hours. The reaction was allowed to warm to room
temperature and then H2O was added slowly till bubbles ceased to form. The reaction mixture
was extracted with Et2O. The organic layers were combined and dried with Na2SO4.
Concentration and flash chromatography in 20% EtOAc/Hex yielded 26 (293 mg, 83%) as a
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clear liquid. Data are: 1H NMR (CDCl3, 500 MHz): δ 4.666 (d, J = 10 Hz, 1H), 3.742 (s, 1H),
2.858 (s, 1H), 2.242 (m, 2H), 1.934 (s, 3H), 1.639 (s, 1H), 1.341 (d, J = 13.5 Hz, 1H), 1.007 (s, 3H),
0.779 (s, 3H), 0.762 (s, 3H), 0.689 (d, J = 13 Hz, 1H); 13C NMR (CDCl3, 125 MHz): δ 171.27, 78.33,
74.76, 52.36, 49.53, 47.28, 39.25, 34.12, 21.07, 20.59, 19.74, 12.78; HRMS found 230.1749
(M+NH4)+, calculated 230.18 for (C12H20O3+NH4)+; [α]D20 +36.5 (c 8.8, CH2Cl2).

(1R,2S,4R,5R)-5-((tert-butyldimethylsilyl)oxy)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl
acetate (27)
26 (255 mg, 1.2 mmol) was added to a 10 mL flame dried round bottom flask with 15 mL DMF
and imidazole (245 mg, 3.6 mmol). The reaction was stirred and cooled to 0° C in an ice bath.
TBSCl (363 mg, 2.4 mmol) was then added in one portion. The reaction was then allowed to
warm to room temperature and was stirred for an additional 24 hours. H2O was then added to
quench the reaction. The reaction mixture was then extracted with Et2O. The organic layers
were combined and dried with Na2SO4. Concentration and flash chromatography in 10%
EtOAc/Hex yielded 27 (390 mg , 99%) as a clear liquid. Data are: 1H NMR (CDCl3, 500 MHz):
δ 4.690 (d, J = 10 Hz, 1H), 3.645 (d, J = 7.5 Hz, 1H), 2.238 (m, 2H), 1.950 (s, 3H), 1.584 (d, J = 5
Hz, 1H), 1.344 (d, J = 13.5 Hz, 1H), 1.011 (s, 3H), 0.818 (s, 3H), 0.786 (s, 12H), 0.684 (d, J = 14.5
Hz, 1H), –0.056 (s, 3H) , –0.062 (s, 3H); 13C NMR (CDCl3, 125 MHz): δ 171.19, 78.47, 75.15,
52.48, 49.28, 47.41, 40.53, 33.94, 25.67, 25.60, 21.00, 20.64, 19.71, 12.75, –4.88, –4.99; HRMS
found 327.2361 (M+H)+, calculated 327.24 for (C18H34O3Si+H)+; [α]D20 +7.98 (c 9.8, CH2Cl2).
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(1R,2S,4R,5R)-5-((tert-butyldimethylsilyl)oxy)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-ol (28)
27 (390 mg, 1.2 mmol) was added to a 25 mL flame dried round bottom flask with 10 mL DCM.
The reaction flask was capped with a rubber septum and purged with N2. After cooling to –40°
C in an acetone bath, DIBAL (1.8 mL, 2.6 mmol, 1.5M in toluene) was added dropwise. The
reaction was stirred at –40° C for 1 hour. 5 mL MeOH was then added slowly followed by 5 mL
Rochelle’s salt’s (saturated aqueous solution). The solution was then stirred vigorously for 2
hours while warming to room temperature. The reaction was then extracted with DCM and
washed with brine. The organic layers were combined and dried with Na2SO4. Concentration
followed by purification using a silica gel plug yielded 28 (337 mg, 99%) as a clear liquid. Data
are: 1H NMR (CDCl3, 500 MHz): δ 3.862 (d, J = 10 Hz, 1H), 3.735 (d, J = 8 Hz, 1H), 2.238 (m,
2H), 1.749 (bs, 1H), 1.610 (d, J = 5.5 Hz, 1H), 1.345 (d, J = 14 Hz, 1H), 1.067 (s, 3H), 0.895 (s, 3H),
0.849 (s, 9H), 0.797 (s, 3H), 0.734 (d, J = 13.5 Hz, 1H), –0.001 (s, 6H); 13C NMR (CDCl3, 125
MHz): δ 75.93, 75.35, 52.92, 47.80, 39.50, 36.06, 25.78, 25.63, 21.14, 19.65, 17.81, 12.73, –4.80,
–4.86; HRMS found 285.2330 (M+H)+, calculated 285.22 for (C16H32O2Si+H)+; [α]D20 –7.50 (c 9.0,

CH2Cl2).
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(1R,2S,4R,5R)-5-((tert-butyldimethylsilyl)oxy)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl
cinnamate (29)
28 (358 mg, 1.3 mmol) was added to a flame dried 50 mL round bottom flask containing 10 mL
DCM. Pyridine (0.3 mL, 3.7 mmol) was added and then the flask was purged with N2 gas. The
reaction was cooled to 0° C in an ice bath. Cinnamoyl chloride (525 mg, 3.2 mmol) was added
in small portions over 10 minutes. After stirring for 2 hours, the reaction was quenched with
10% HCl (aq.) and extracted with DCM. Organic layers were combined and dried with Na2SO4.
Concentration and flash chromatography in 10% EtOAc/Hex yielded 29 (434 g, 83%) as a clear
liquid. Data are: 1H NMR (CDCl3, 500 MHz): δ 7.668 (d, J = 16.5 Hz, 1H), 7.516 (s, 2H), 7.355 (s,
3H), 6.456 (d, J = 16.5 Hz, 1H), 4.936 (d, J = 8.5 Hz, 1H), 3.804 (s, 1H), 2.423 (m, 2H), 1.714 (s,
1H), 1.502 (d, J = 13.5 Hz, 1H), 1.135 (s, 3H), 0.916 (s, 6H), 0.897 (s, 10H), 0.051 (s, 6H); 13C NMR
(CDCl3, 125 MHz): δ 166.96, 144.34, 134.52, 130.14, 128.82, 128.05, 118.63, 78.53, 75.32, 52.68,
49.66, 47.61, 40.82, 34.23, 25.84, 20.82, 19.92, 17.86, 13.01, –4.68, –4.79; HRMS found 415.2641
(M+H)+, calculated 415.27 for (C25H38O3Si+H)+; [α]D20 –10.00 (c 10.8, CH2Cl2).
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(1R,2S,4R,5R)-5-hydroxy-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl cinnamate (29a)
29 (425 mg, 1.0 mmol) and 15 mL CH3CN was added to a 25 mL Teflon tube. The reaction was
cooled to 0° C in an ice bath. HF·pyridine (0.2 mL, 70% by vol., 7.0 mmol) was added by
syringe to the reaction which was then allowed to warm to room temperature. Stirring continued
for 1 day. The reaction was then quenched with H2O and extracted with DCM. Organic layers
were combined and dried with Na2SO4. Concentration and flash chromatography in 20%
EtOAc/Hex yielded 29a (300 mg, 97%) as a clear liquid. Data are: 1H NMR (CDCl3, 500 MHz):
δ 7.636 (d, J = 16.5 Hz, 1H), 7.494 (s, 2H), 7.344 (s, 3H), 6.417 (d, J = 16.5 Hz, 1H), 3.911 (d, J =
7.5 Hz, 1H), 3.912 (s, 1H), 2.606 (bs, 1H), 2.442 (m, 2H), 1.777 (s, 1H), 1.516 (d, J = 13 Hz, 1H),
1.135 (s, 3H), 0.910 (s, 7H); 13C NMR (CDCl3, 125 MHz): δ 167.17, 144.55, 134.39, 130.26, 128.86,
128.06, 118.44, 78.48, 75.04, 52.61, 49.93, 47.48, 39.55, 34.36, 20.75, 19.91, 12.98; HRMS found
301.1921 (M+H)+, calculated 301.18 for (C19H24O3+H)+; [α]D20 +23.05 (c 7.5, CH2Cl2).

(1R,2S,4R,5R)-5-(2-((tert-butyldimethylsilyl)oxy)acetoxy)-1,7,7trimethylbicyclo[2.2.1]heptan-2-yl cinnamate (29b)
2,4,6-trichlorobenzoyl chloride (315 mg, 1.3 mmol), 2-((tert-butyldimethylsilyl)oxy)acetic acid
(208 mg, 1.1 mmol), 3 mL Et3N, and 10 mL THF were added to a 50 mL flame dried round
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bottom flask and stirred for 12 hours. 29a (298 mg, 1.0 mmol) and DMAP (243 mg, 2.0 mmol)
were then added and allowed to react for 18 hours. The reaction was then quenched with H2O
and extracted with DCM. The organic layers were combined and dried with Na2SO4.
Concentration and flash chromatography in 5% EtOAc/ Hex yielded 29b (139 mg, 30%) as a
clear liquid. Data are: 1H NMR (CDCl3, 500 MHz): δ 7.656 (d, J = 16 Hz, 1H), 7.529 (d, J = 5 Hz,
2H), 7.374 (s, 3H), 6.439 (d, J = 16 Hz, 1H), 4.967 (d, J = 9 Hz, 1H), 4.786 (d, J = 8 Hz, 1H), 4.197
(s, 2H), 2.581 (dd, J = 14, 8.5 Hz, 1H), 2.494 (m, 1H), 1.973 (d, J = 5 Hz, 1H), 1.580 (d, J = 14 Hz,
1H), 1.034 (s, 3H), 0.941 (s, 3H), 0.929 (s, 3H), 0.916 (s, 9H), 0.873 (s, 1H), 0.101 (s, 6H); 13C NMR
(CDCl3, 125 MHz): δ 171.23, 166.96, 144.66, 134.39, 130.25, 128.86, 128.08, 118.28, 77.84, 77.56,
61.97, 49.90, 47.67, 37.18, 34.02, 25.79, 25.74, 20.45, 19.54, 18.34, 12.76, –4.72, –5.44; HRMS
found 473.2970 (M+H)+, calculated 473.27 for (C27H40O5Si+H)+; [α]D20 –14.57 (c 3.3, CH2Cl2).

(1R,2S,4R,5R)-5-(2-hydroxyacetoxy)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl cinnamate
(19)
29b (133 mg, 0.28 mmol) and 10 mL CH3CN were added to a 25 mL Teflon tube.. The reaction
was cooled to 0° C in an ice bath. HF·pyridine (0.2 mL, 70% by vol., 2.8 mmol) was added by
syringe to the reaction and then stirred for 4 hours. The reaction was quenched with H2O and
extracted with DCM. Organic layers were combined and dried with Na2SO4. Concentration and
flash chromatography in 10% EtOAc/Hex yielded 19 (58 mg, 58%) as a clear liquid. Data are:
1

H NMR (CDCl3, 500 MHz): δ 7.664 (d, J = 16 Hz, 1H), 7.534 (d, J = 4 Hz, 2H), 7.380 (s, 3H),

6.447 (d, J = 16 Hz, 1H), 4.962 (d, J = 9.5 Hz, 1H), 4.836 (d, J = 8.5 Hz, 1H), 4.116 (s, 2H), 2.588
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(m, 2H), 2.514 (m, 1H), 1.982 (d, J = 6 Hz, 1H), 1.603 (d, J = 14.5 Hz, 1H), 1.049 (d, J = 14.5 Hz,
1H), 1.016 (s, 3H), 0.945 (s, 3H), 0.933 (s, 3H); 13C NMR (CDCl3, 125 MHz): δ 172.82, 166.99,
144.79, 134.35, 130.31, 128.88, 128.09, 118.19, 78.43, 77.72, 60.78, 49.92, 49.88, 47.67, 37.06,
33.94, 20.38, 19.49, 12.71; HRMS found 359.1906 (M+H)+, calculated 359.19 for (C21H26O5+H)+;

[α]D20 –22.10 (c 1.46, CH2Cl2).
4.4.3 Fenchyl Mimic

(1R,2R,4S)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl acetate (16)
(+)-Fenchol 31 (1 g, 6.5 mmol) and 20 mL DCM were added to a 50 mL flame dried round
bottom flask. Pyridine (2.5 mL, 31 mmol) was added and the reaction flask was purged with N2.
After cooling the reaction to 0° C, acetyl chloride (2.3 mL, 32 mmol) was added dropwise to the
reaction. The reaction was stirred for 1 hour and then quenched with H2O and extracted with
DCM. The combined organic layers were then dried with Na2SO4. Concentration and flash
chromatography in 5% EtOAc/Hex yielded 16 (1.25 g, 98%) as a clear liquid. Data are: 1H
NMR (CDCl3, 500 MHz): δ 4.361 (s, 1H), 2.075 (s, 3H), 1.714 (m, 3H), 1.576 (d, J = 10 Hz, 1H),
1.449 (m, 1H), 1.183 (d, J = 10 Hz, 1H), 1.100 (s, 3H), 1.066 (d, J = 11.5 Hz, 1H), 1.039 (s, 3H),
0.778 (s, 3H); 13C NMR (CDCl3, 125 MHz): δ 171.59, 86.13, 48.32, 48.15, 41.37, 39.40, 29.71,
26.55, 25.81, 20.97, 20.03, 19.36; HRMS found 137.1349 (M–AcOH+H)+, calculated 137.13 for
(C10H16+H)+; [α]D20 +45.75 (c 6.1, CH2Cl2).
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(1S,2R,4S)-1,3,3-trimethyl-5-oxobicyclo[2.2.1]heptan-2-yl acetate (17)
16 (6.1 g, 31.1 mmol) was added to a flame dried round bottom flask with 5 mL AcOH. The
flask was topped with a water condenser and heated to reflux (115° C) with a sand bath. CrO3
(10.9 g, 109 mmol) was dissolved in 3 mL AcOH. The chromium solution was added dropwise
over 1 hour. The reaction was then allowed to stir at reflux for 1.5 hours. A second CrO3
solution was prepared (10.9 g, 109 mmol) and added to the reaction over 1 hour. After refluxing
for another 1.5 hours, the reaction was quenched with H2O and extracted with Et2O. The Et2O
extracts were combined and neutralized with NaHCO3. The organic layer was then dried with
Na2SO4. Concentration and flash chromatography in 10% EtOAc/Hex yielded 17 (3.04 g, 46%)
as a clear liquid. Data are: 1H NMR (CDCl3, 500 MHz): δ 4.582 (s, 1H), 2.408 (dd, J = 18.5, 4 Hz,
1H), 2.179 (s, 1H), 2.043 (s, 3H), 1.897 (dd, J = 11, 4.5 Hz, 1H), 1.749 (d, J = 18.5 Hz, 1H), 1.550
(d, J = 11.5 Hz, 1H), 1.234 (s, 3H), 1.178 (s, 3H) , 0.778 (s, 3H); 13C NMR (CDCl3, 125 MHz): δ
215.76, 171.23, 84.00, 62.88, 60.42, 46.71, 43.57, 39.12, 28.32, 21.14, 19.22, 14.18; HRMS found
211.1348 (M+H)+, calculated 211.13 for (C12H18O3+H)+; [α]D20 +11.50 (c 100.2, CH2Cl2).

80

(1S,2R,4S,5S)-5-hydroxy-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl acetate (32)
17 (289 mg, 1.4 mmol) was added to a flame dried 25 mL round bottom flask with 10 mL MeOH
and CeCl3·7H2O (1.54 g, 4.1 mmol). The reaction was stirred at room temperature for 30
minutes and then cooled to –78° C in an acetone bath with dry ice. NaBH4 (104 mg, 2.7 mmol)
was added in small portions over 2 hours. The reaction was allowed to warm to room
temperature and then H2O was added slowly until bubbles ceased to form. The reaction mixture
was extracted with Et2O. The organic layers were combined and dried with Na2SO4.
Concentration and flash chromatography in 20% EtOAc/Hex yielded 32 (277 mg, 95%) as a
clear liquid. Data are: 1H NMR (CDCl3, 500 MHz): δ 4.436 (s, 1H), 4.354 (m, 1H), 2.094 (s, 3H),
2.049 (d, J = 11.5 Hz, 1H), 1.798 (s, 1H), 1.722 (m, 1H), 1.605 (m, 2H), 1.523 (d, J = 11.5 Hz, 1H),
1.208 (d, J = 10.5 Hz, 1H), 1.134 (s, 3H) , 1.083 (s, 3H) , 1.001 (s, 3H); 13C NMR (CDCl3, 125
MHz): δ 171.58, 85.73, 75.77, 53.00, 48.40, 39.88, 39.57, 35.06, 31.47, 21.49, 20.97, 19.79; HRMS
found 213.1469 (M+H)+, calculated 213.15 for (C12H20O3+H)+; [α]D20 +54.25 (c 6.9, CH2Cl2).
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(1S,2R,4S,5S)-1,3,3-trimethyl-5-((triethylsilyl)oxy)bicyclo[2.2.1]heptan-2-yl acetate (33)
32 (277 mg, 1.3 mmol) was added to a 10 mL flame dried round bottom flask with 5 mL DMF
and imidazole (267 mg, 5.1 mmol). The reaction was stirred and cooled to 0° C in an ice bath.
TESCl (0.44 mL, 2.6 mmol) was then added in one portion. The reaction was then allowed to
warm to room temperature and was stirred for an additional 24 hours. H2O was then added to
quench the reaction and then it was extracted with Et2O. The organic layers were combined and
dried with Na2SO4. Concentration and flash chromatography in 10% EtOAc/Hex yielded 33
(393 mg , 92%) as a clear liquid. Data are: 1H NMR (CDCl3, 500 MHz): δ 4.411 (s, 1H), 4.249
(m, 1H), 2.080 (s, 3H), 1.706 (m, 2H), 1.491 (m, 2H), 1.159 (d, J = 10.5 Hz, 1H), 1.111 (s, 3H),
1.053 (s, 3H), 0.983 (s, 3H), 0.956 (t, J = 8 Hz, 9H), 0.569 (q, J = 8 Hz, 6H); 13C NMR (CDCl3, 125
MHz): δ 171.37, 85.97, 75.16, 53.23, 48.08, 39.87, 39.06, 35.91, 31.46, 21.32, 20.77, 19.80, 6.73,
4.67; HRMS found 327.2491 (M+H)+, calculated 327.24 for (C18H34O3Si+H)+; [α]D20 +37.65 (c

13.1, CH2Cl2).
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(1S,2R,4S,5S)-5-((tert-butyldimethylsilyl)oxy)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl
acetate (33a)
32 (1.638 g, 7.7 mmol) was added to a 10 mL flame dried round bottom flask with 5 mL DMF
and imidazole (1.58 g, 23.2 mmol). The reaction was stirred and cooled to 0° C in an ice bath.
TBSCl (2.33 g, 15.5 mmol) was then added in one portion. The reaction was then allowed to
warm to room temperature and was stirred for an additional 24 hours. H2O was then added to
quench the reaction and then it was extracted with Et2O. The organic layers were combined and
dried with Na2SO4. Concentration and flash chromatography in 10% EtOAc/Hex yielded 33a
(2.339 g, 93%) as a clear liquid. Data are: 1H NMR (CDCl3, 500 MHz): δ 4.413 (s, 1H), 4.237 (m,
1H), 2.101 (s, 3H), 1.686 (m, 2H), 1.484 (m, 2H), 1.163 (d, J = 11.5 Hz, 1H), 1.112 (s, 3H), 1.041 (s,
3H), 0.984 (s, 3H), 0.886 (s, 9H), 0.032 (s, 3H), 0.025, (s, 3H); 13C NMR (CDCl3, 125 MHz): δ
171.68, 86.03, 75.45, 53.19, 48.18, 39.91, 39.11, 35.90, 31.55, 25.83, 21.65, 19.92, 17.97, –4.90,
–4.95; HRMS found 327.2370 (M+H)+, calculated 327.24 for (C18H34O3Si+H)+; [α]D20 +39.57 (c

5.35, CH2Cl2).
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(1S,2R,4S,5S)-1,3,3-trimethyl-5-((triethylsilyl)oxy)bicyclo[2.2.1]heptan-2-ol (34)
a) 33 (393 mg, 1.2 mmol) was added to a 25 mL flame dried round bottom flask with 5 mL
DCM. The reaction flask was capped with a rubber septum and purged with N2. After cooling
to –40° C in an acetone bath, DIBAL (1.8 mL, 2.6 mmol, 1.5M in toluene) was added dropwise.
The reaction was stirred at –40° C for 1 hour. 5 mL MeOH was then added slowly followed by 5
mL Rochelle’s salt’s (sat.aq.). The solution was then stirred vigorously for 2 hours while
warming to room temperature. The reaction was then extracted with DCM and washed with
brine. The organic layers were combined and dried with Na2SO4. Concentration and flash
chromatography in 5% EtOAc/Hex yielded 34 (243 mg, 71%) as a clear liquid. Data are: 1H
NMR (CDCl3, 500 MHz): δ 4.138 (m, 1H), 3.208 (d, J = 6 Hz, 1H), 1.694 (d, J = 6 Hz, 1H), 1.598 (s,
1H), 1.482 (m, 1H), 1.353 (t, J = 11 Hz, 1H), 1.292 (d, J = 10.5 Hz, 1H), 1.073 (s, 3H), 1.017 (d, J =
10.5 Hz, 1H), 0.961 (s, 3H), 0.929 (s, 3H), 0.873 (t, J = 7.5 Hz, 9H), 0.483 (q, J = 7.5 Hz, 6H); 13C
NMR (CDCl3, 125 MHz): δ 84.97, 75.31, 52.87, 49.30, 39.58, 38.75, 34.74, 32.53, 21.53, 19.99,
6.77, 4.71; HRMS found 285.2224 (M+H)+, calculated 285.22 for (C16H32O2Si+H)+; [α]D20 +14.34

(c 8.11, CH2Cl2).
b) 35 (24 mg, 85 μmol) was added to a 25 mL flame dried round bottom flask with 10 mL THF.
The reaction was then cooled to –78° C in an acetone and dry ice bath. 10 mL NH3 was then
bubbled into the reaction by cannula. 5 mg pieces of Li metal were added to the reaction until
the solution turned a bright blue. After the reaction was blue for 5 minutes, the reaction was
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quenched with NH4Cl (8.7 mg, 0.16 mmol) and then warmed to room temperature. The reaction
was then extracted with DCM and dried with Na2SO4. Filtration through a silica cup with ether
and concentration gave 34 (24 mg, 100%) as a clear liquid.

(1S,2R,4S,5S)-5-((tert-butyldimethylsilyl)oxy)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-ol
(34a)
33a (2.518 g, 7.7 mmol) was added to a 25 mL flame dried round bottom flask with 5 mL DCM.
The reaction flask was capped with a rubber septum and purged with N2. After cooling to –40°
C in an acetone bath, DIBAL (11.3 mL, 17.3 mmol, 1.5M in toluene) was added dropwise. The
reaction was stirred at –40° C for 1 hour. 5 mL MeOH was then added slowly followed by 5 mL
Rochelle’s salt’s (sat.aq.). The solution was then stirred vigorously for 2 hours while warming to
room temperature. The reaction was then extracted with DCM and washed with brine. The
organic layers were combined and dried with Na2SO4. Concentration and flash chromatography
in 5% EtOAc/Hex yielded 34a (1.651 g, 75%) as a clear liquid. Data are: 1H NMR (CDCl3, 500
MHz): δ 4.154 (m, 1H), 3.236 (s, 1H), 1.868 (d, J = 5.5 Hz, 1H), 1.620 (s, 1H), 1.508 (m, 2H), 1.364
(t, J = 11.5 Hz, 1H), 1.314 (d, J = 11.5 Hz, 1H), 1.090 (s, 3H), 1.045 (d, J = 11 Hz, 1H), 0.988 (s,
3H), 0.953 (s, 3H), 0.831 (s, 9H), –0.029 (s, 6H); 13C NMR (CDCl3, 125 MHz): δ 84.88, 75.57,
52.79, 49.30, 39.53, 38.70, 34.58, 32.52, 25.82, 21.87, 20.06, –4.94, –5.03; HRMS found 285.2288
(M+H)+, calculated 285.22 for (C16H32O2Si+H)+; [α]D20 +19.66 (c 15.29, CH2Cl2).
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(1S,4S,5S)-1,3,3-trimethyl-5-((triethylsilyl)oxy)bicyclo[2.2.1]heptan-2-one (35)
34 (243 mg, 0.85 mmol) was added to a 25 mL flame dried round bottom flask with 10 mL
DCM. TPAP (15 mg, 43 μmol) and anhydrous NMO (200 mg, 1.7 mmol) were added and then
the reaction was stirred for 24 hours. After starting material was consumed, the reaction mixture
was filtered through a silica gel cup to remove TPAP. The filtrate was then concentrated and
flash chromatography in 5% EtOAc/Hex yielded 35 (197 mg, 82%) as a clear liquid. Data are:
1

H NMR (CDCl3, 500 MHz): δ 4.464 (m, 1H), 2.138 (s, 1H), 1.973 (dd, J = 10, 13 Hz, 1H), 1.692 (d,

J = 11 Hz, 1H), 1.513 (d, J = 11 Hz, 1H), 1.341 (s, 3H), 1.088 (s, 3H), 1.060 (s, 3H), 0.940 (t, J = 8
Hz, 9H), 0.566 (q, J = 8 Hz, 6H); 13C NMR (CDCl3, 125 MHz): δ 222.53, 73.98, 54.18, 50.53, 47.86,
41.51, 39.56, 25.57, 23.12, 15.19, 6.78, 4.65; HRMS found 283.2118 (M+H)+, calculated 283.20 for
(C16H30O2Si+H)+; [α]D20 –15.23 (c 6.6, CH2Cl2).

(1S,2S,4S,5S)-1,3,3-trimethyl-5-((triethylsilyl)oxy)bicyclo[2.2.1]heptan-2-ol (37)
Fenchone 36 (2 mL, 12.5 mmol) was added to a 50 mL flame dried round bottom flask with 25
mL i-PrOH and AlCl3 (804 mg, 6 mmol). The reaction was topped with a water condenser and
heated to 85° C. The reaction was checked by TLC in 10% EtOAc/Hex after 24 hours. No
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conversion was observed. The reaction was stirred for 2 weeks and checked again. No products
were observed and monitoring was discontinued.

(1R,2S,4S)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl 2-chloroacetate (38)
(+)-Fenchol 31 (2 g, 13 mmol) was added to a 100 mL flame dried round bottom flask containing
50 mL toluene. Triphenylphosphine (6.8 g, 26 mmol) and 2-chloroacetic acid (2.45 g, 26 mmol)
were added and the reaction was stirred for 5 minutes. (E)-Diisopropyl diazene-1,2dicarboxylate (5 mL, 26 mmol) was then added dropwise by syringe. The resulting yellow
solution was stirred at room temperature for 24 hours. The solution was then checked by TLC in
10% EtOAc/Hex which showed no conversion to any product. Monitoring was discontinued.

(1S,2R,4S,5S)-5-((tert-butyldimethylsilyl)oxy)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl
cinnamate (39)
34 (1.48 g, 5.2 mmol) was added to a flame dried 50 mL round bottom flask containing 50 mL
DCM. Pyridine (1.1 mL, 13.7 mmol) was added and then the flask was purged with N2 gas. The
reaction was cooled to 0° C in an ice bath. Cinnamoyl chloride (2.17 mg, 13.0 mmol) was added
in small portions over 10 minutes. After stirring for 2 hours, the reaction was quenched with
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10% HCl (aq.) and extracted with DCM. Organic layers were combined and dried with Na2SO4.
Concentration and flash chromatography in 10% EtOAc/Hex yielded 39 (1.95 g, 90%) as a clear
liquid. Data are: 1H NMR (CDCl3, 500 MHz): δ 7.703 (d, J = 16 Hz, 1H), 7.558 (m, 2H), 7.397 (m,
3H), 6.515 (d, J = 16 Hz, 1H), 4.573 (d, J = 2 Hz, 1H), 4.283 (m, 1H), 1.797 (m, 1H), 1.750 (s, 1H),
1.553 (m, 2H), 1.207 (d, J = 11 Hz, 1H), 1.167 (s, 3H), 1.094 (s, 3H), 1.037 (s, 3H), 0.901 (s, 9H),
0.062 (s, 3H), 0.042 (s, 3H); 13C NMR (CDCl3, 125 MHz): δ 167.28, 144.34, 134.56, 130.15, 128.84,
128.08, 118.53, 86.01, 75.53, 53.29, 48.46, 40.27, 39.24, 36.18, 31.68, 25.92, 21.92, 20.08, 18.00,
–4.78, –4.85; HRMS found 415.2757 (M+H)+, calculated 415.27 for (C25H38O3Si+H)+; [α]D20

+11.02 (c 3.7, CH2Cl2).

(1S,2R,4S,5S)-5-hydroxy-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl cinnamate (40)
39 (1.95 g, 4.7 mmol) and 15 mL CH3CN was added to a 25 mL Teflon tube. The reaction was
cooled to 0° C in an ice bath. HF·pyridine (1.2 mL, 70% by vol., 19.3 mmol) was added by
syringe to the reaction which was then allowed to warm to room temperature. Stirring continued
for 1 day. The reaction was then quenched with H2O and extracted with DCM. Organic layers
were combined and dried with Na2SO4. Concentration and flash chromatography in 20%
EtOAc/Hex yielded 40 (735 mg, 52%) as a clear liquid. Data are: 1H NMR (CDCl3, 500 MHz): δ
7.619 (d, J = 16 Hz, 1H), 7.434 (s, 2H), 7.273 (s, 3H), 6.425 (d, J = 16 Hz, 1H), 5.071 (d, J = 18 Hz,
1H), 4.488 (s, 1H), 4.087 (m, 1H), 3.773 (m, 2H), 1.785 (m, 4H), 1.503 (m, 2H), 1.107 (s, 3H), 0.973
(s, 6H); 13C NMR (CDCl3, 125 MHz): δ 167.22, 144.33, 134.44, 130.12, 128.78, 128.03, 118.38,
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104.08, 86.03, 80.47, 66.98, 52.19, 40.01, 32.21, 31.36, 23.54, 19.84; HRMS found 301.1831
(M+H)+, calculated 301.18 for (C19H24O3+H)+.

(1S,2R,4S,5S)-5-(2-((tert-butyldimethylsilyl)oxy)acetoxy)-1,3,3trimethylbicyclo[2.2.1]heptan-2-yl cinnamate (41)
40 (364 mg, 1.2 mmol) and 10 mL DCM were added to a 50 mL flame dried round bottom flask.
Imidazole (300 mg, 4.4 mmol) was added to the reaction flask and then purged with N2. 2((tert-butyldimethylsilyl)oxy)acetyl chloride 24 (837 mg, 4.0 mmol) was added in one portion to
the reaction and stirred for 4 hours. The reaction was then quenched with H2O and extracted
with DCM. The organic layers were combined and dried with Na2SO4. Concentration and flash
chromatography in 10% EtOAc/ Hex yielded 41 (258 mg, 45%) as a clear liquid. Data are: 1H
NMR (CDCl3, 500 MHz): δ 7.654 (d, J = 16 Hz, 1H), 7.486 (s, 2H), 7.320 (s, 3H), 6.459 (d, J = 16
Hz, 1H), 5.116 (d, J = 18.5 Hz, 1H), 4.511 (s, 1H), 4.121 (m, 1H), 3.822 (m, 2H), 1.847 (m, 4H),
1.550 (m, 2H), 1.130 (s, 3H), 0.998 (s, 6H), 0.866 (s, 9H), 0.037 (s, 6H); Calculated 473.27 for
(C27H40O5Si+H)+.
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(1S,2R,4S,5S)-5-(2-hydroxyacetoxy)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl cinnamate
(42)
41 (258 mg, 0.55 mmol) and 10 mL CH3CN were added to a 25 mL Teflon tube. The reaction
was cooled to 0° C in an ice bath. HF·pyridine (0.3 mL, 70% by vol., 12.1 mmol) was added by
syringe to the reaction and then stirred for 4 hours. The reaction was quenched with H2O and
extracted with DCM. Organic layers were combined and dried with Na2SO4. Concentration and
flash chromatography in 20% EtOAc/Hex yielded 42 (118 mg, 60%) as a clear liquid. Data are:
1

H NMR (CDCl3, 500 MHz): δ 7.701 (d, J = 16 Hz, 1H), 7.550 (s, 2H), 7.388 (s, 3H), 6.512 (d, J =

16 Hz, 1H), 5.171 (d, J = 19 Hz, 1H), 4.560 (s, 1H), 4.179 (m, 1H), 3.875 (m, 2H), 1.861 (m, 4H),
1.600 (m, 2H), 1.178 (s, 3H), 1.050 (s, 3H), 1.032 (s, 3H); Calculated 359.19 for (C21H26O5+H)+.
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